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Open chromatin is induced locally during the repair of DNA double strand 
breaks, when a cascade of protein recruitments and modifications is triggered. This 
"ATM cascade" includes components like the Mrn complex, ATM kinase, 
phosphorylated histon variant γH2AX, MDC1, E3 ligases RNF 8 and RNF8, 53BP1, and 
Rif1. Recent investigations have shown that also the Mad2l2 protein is a 
downstream effector of the ATM cascade during DNA repair. It was first described as 
an accessory subunit during translesion DNA repair, and more recently as a key 
factor inhibiting the resection of DNA 5`ends, thus promoting non-homologous end 
joining, and repressing homologous recombination. 
Naive embryonic stem cells (ESCs) have a globally open chromatin. A 
preliminary study from this laboratory has demonstrated that ESCs require the 
presence of the Mad2l2 protein for the maintenance of their transcriptional and 
epigenetic profiles, and thus for the stability of pluripotency (Pirouz et al., Cell Cycle 
14, 1596, 2015). The aim of the present study was to correlate Mad2l2 with the ATM 
cascade and the chromatin status in ESCs. 
Mad2l2 as well as several other components of the ATM cascade are 
expressed at extraordinary high levels in the euchromatin of ESCs. High-resolution 
microscopy revealed that the localization of heterochromatin markers (H3K9me2 
and H3K27me3) and Mad2l2 were mutually exclusive. In the absence of Mad2l2 the 
methylation of DNA and the amount of heterochromatin increased significantly. 
Comparative gene expression profiling indicated a striking, activating effect of 
Mad2l2 on the expression of Dppa3, a common marker of naive ESCs and primordial 
germ cells. Mass spectrometry identified Mad2l2 partners as a direct interactor of 
ATM cascade proteins, and DNA methyltransferase I (Dnmt1) in the ESC chromatin. 
Mad2l2 interaction with Dnmt1 had a substantial impact on the expression of 
imprinted genes in ESCs, which were downregulated in mutant ESCs. Inhibition of 
ATM, ATR and DNA-PK kinases supported the position of Mad2l2 as a downstream 
effector in the ATM cascade, just upstream of a DNA-Pk mediated Dppa3 activity. 
The suppression of Dppa3 in the absence of Mad2l2 was at least partially achieved 
by an occupation of the promoter with H3K9me2. Further epigenetic effects related 
to Mad2l2 were the loss of the mutually exclusive localization of 53BP1 and 
H3K27me, and the necessity of Mad2l2 for the epigenetic reprogramming of ESCs 
into germ cells in vitro. 
In conclusion, this study provides evidence for the function of Mad2l2 as a 
downstream effector in the constitutive ATM cascade in ESCs. This implies that the 
importance of Mad2l2 for DNA repair, germ cell development and ESC stability lies in 
the epigenetic regulation of the chromatin status. 
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1. Introduction 
1.1. Pluripotency in peri-implantation embryos 
The fusion of haploid egg and sperm results in the formation of a diploid, 
one-cell embryo, or the zygote. In mammals, this single cell is capable of developing 
into all embryonic and extraembryonic tissues. It shares this "totipotency" with its 
daughter cells during the next cleavage divisions. The first divisions lead to a 
compact, round shaped embryo with 8 or 16 cells, the morula, which is surrounded 
by a cell-free membrane, the zona pellucida. Morula cells have to make a first 
developmental decision, to become either extraembryonal trophectoderm or inner 
cell mass (ICM) (Frum and Ralston, 2015; Zernicka-Goetz, 2005). 
 By embryonic day E3.5 the early blastocyst consists of 32 cells in the ICM, 
surrounded by the trophectoderm, also called trophoblast. ICM cells lack the 
potential to generate a trophectoderm, but retain the remarkable developmental 
potential to develop into all other cell types of the body, including germ cells. This 
potential has been defined as pluripotency (De Los Angeles et al.; Frum and Ralston, 
2015). Pluripotent cells are characterized by the homogeneous expression of three 
core transcription factors, namely Oct4, Sox2 and Nanog (Ohnishi et al., 2014). 
Epigenetically, ICM cells in early blastocyst have high levels of activating histone 3 
modifications around transcription start sites (H3K4me1, H3K4me2, and H3K4me3). 
Their DNA is significantly hypomethylated, and both X chromosomes are active (Li et 
al., 2012). The mid blastocyst ICM consists of a heterogeneous cell population, with 
fluctuating levels of Nanog and other pluripotency related markers (Xenopoulos et 
al., 2015). Several regulatory genes bear at the same time activating and repressive 
epigenetic signatures (Vastenhouw and Schier, 2012). For example, genes like Gata4 
and Sox17 are characterized simultaneously by H3K4me3 and H3K27me3 histones. 
This epigenetic configuration termed bivalency is typical for pluripotent cells. It 
maintains lineage commitment in a poised state (Li et al., 2012).  
 The late blastocyst containing more than 64 ICM cells implants into the 
uterus. Now the ICM cells are ready to make a second fundamental decision, namely 
between an embryonic and an extra-embryonic fate. The embryonic cells, now 
designated the epiblast, maintain their pluripotent potential, including the 
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expression of Oct4 and Sox2, while Nanog expression is downregulated, and early 
ICM markers such as Dppa3 (formerly Stella) and Zfp42 (formerly Rex1) are 
completely silenced (Joo et al., 2014). Prospective extra-embryonic, visceral 
endoderm cells are distinguished from epiblast cells by their peripheral location, and 
by the expression of Gata4 and Sox17 (Bao et al., 2009). The pluripotent potential of 
the early post-implantation epiblast is quickly lost upon further development 
towards gastrulation. Now the embryo will develop the three germ layers, acquire a 
cylinder shape ("egg cylinder"), and become asymmetric along the proximal-distal as 
well as the anterior-posterior axis (Stower and Srinivas, 2014).  
 
 
Figure 1: Early embryonic development from zygote to late blastocyst. 
Mouse embryonic development starts with the formation of the zygote, in which the 
paternal and the maternal pronuclei initially are not fused yet. It takes three days for a 
zygote to develop into a morula, a condensed sphere of 16 cells. Around E3.5, a hollow ball 
of cells, the blastocyst, has formed. The cells in outer layer represent the trophoblast, and 
the cells inside the inner cell mass (ICM). Blastocyst development occurs in three stages, so 
that early, mid and late blastocysts are observed on E3.5, E3.75 and E4.5, respectively.  
 
On day E6 around 20 somatic cells at the interface between extra embryonic 
and embryonic mesoderm become induced by BMP signaling, and acquire a specific 
fate as primordial germ cells (PGCs) (Lawson et al., 1999; Okamura et al., 2005). They 
are identified by expression of the marker genes Prdm1 (Blimp1) and Nanos3. After 
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one day other PGC-related markers are detectable, including several typical 
pluripotency-related markers such as also Dppa3 (Saitou and Yamaji, 2012). Between 
E8 and E9 early PGCs become epigenetically reprogrammed, most significantly by a 
global reduction of histone 3 lysine 9 dimethylation (H3K9me2) and an increase of 
histone 3 lysine 27 trimethylation (H3K27me3), while DNA methylation becomes 
globally reduced (Kurimoto et al., 2015; Seki et al., 2007). 
 
1.2. Embryonic stem cells  
Embryonic stem cells (ESCs) can be derived from the ICM of early or late 
blastocysts before implantation (De Los Angeles et al., 2015). ESCs are characterized 
by their potential for unlimited self-renewal in culture and can differentiate into 
almost any ectodermal, mesodermal and endodermal cell lineage (De Los Angeles et 
al., 2015). Their specific pluripotent potential and their distinct functional properties 
depend not only on their embryonic origin, but significantly also on culture 
conditions. Thus, they may differ with respect to epigenetic profiles (DNA 
methylation patterns, histone modifications) and transcriptional profiles. Based on 
such parameters ESCs have been categorized into naive, metastable or transient, 
and primed subtypes (De Los Angeles et al., 2015). 
 
1.2.1. Naive embryonic stem cells  
Naive ESCs are cultured in a medium containing serum, and leukemia 
inhibitory factor (LIF), supplemented with two inhibitors (2i) directed against MEK 
and GSK3 signaling (De Los Angeles et al., 2015). MEK inhibition blocks 
differentiation pathways triggered by tyrosine kinase inducing factors, and GSK3 
inhibition supports ESCs proliferation. 2i propagated ESCs resemble ICM cells of early 
blastocysts (Ying et al., 2008). Naive pluripotency is considered to represent a 
developmental ground state, as opposed to transient and primed pluripotency as 
defined below (Marks et al., 2012; Tosolini and Jouneau, 2016). The epigenetic 
landscape of naive ESCs is similar to the early inner cell mass, with a high level of 
H3K4me3 associated with both pluripotency and lineage specification marker genes, 
and a low number of bivalent loci (Marks et al., 2012). Their DNA is globally 
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hypomethylated and both X chromosomes are reactivated (Marks et al., 2012; Singer 
et al., 2014). Naive ESC cultures display a homogeneous expression of pluripotency-
associated factors (Oct4, Sox2, Klf3), and are further characterized by naive ESC 
markers such as Dppa3, Zfp42, Prdm14, Klf2, and Esrrb, whereas early lineage 
specification markers are completely silenced (Kolodziejczyk et al., 2015; Marks et 
al., 2012; Singer et al., 2014). There are just few markers to distinguish naive ESCs 
from other ESCs. One of these is Dppa3, a highly specific marker for naive ESCs and 
for primordial germ cells. Dppa3 is also expressed in those 20 percent of metastable 
ESCs which are in a naive state at the time of observation (see below). Dppa3 is 
completely suppressed in primed ESCs. Overexpression of Dppa3 in combination 
with Oct4, Sox2, and Klf3 enhances the induction of pluripotency in mouse 
embryonic fibroblasts (MEFs), at least partially via promotion of global DNA 
demethylation (Funaki et al., 2014; Xu et al., 2015b). Dppa3-deficient mice develop 
normally in the first generation, but the second generation does not survive the 4-
cell stage (Bortvin et al., 2004). In the zygote, Dppa3 is unequally distributed 
between the paternal and maternal pronucleus (Bian and Yu, 2014). It binds to 
methylated DNA and protects the methylation state of e.g. imprinted loci by the 
inhibition of Tet1 and 2 (Kolodziejczyk et al., 2015; Marks et al., 2012; Singer et al., 
2014). 
 
1.2.2. Metastable or transient ESCs 
Metastable or transient ESCs can be isolated from ICMs of both early and 
mid-blastocysts, but resemble more closely the mid-blastocyst on E4.5 (De Los 
Angeles et al., 2015). They are established in culture medium containing LIF and 
serum, on a feeder layer of mitotically inactive mouse embryonic fibroblasts (MEFs). 
LIF supports pluripotency by activation of the signal transducer STAT3 and 
consequently the induction of several pluripotency related transcription factors, 
especially Nanog (Stuart et al., 2014). Bone morphogenesis protein 4 (BMP4) in the 
presence of LIF is another extrinsic factor necessary for the culture of metastable 
mESCs. BMP4 induces expression of the Id gene (inhibition of differentiation) family, 
and inhibition of MAP kinase activity (Stuart et al., 2014). The epigenome of 
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metastable ESCs is characterized by an increased number of bivalent loci, which keep 
lineage specification markers under negative control. Metastable ESCs oscillate 
between a naive and a primed state of pluripotency, which is documented by the 
heterogeneous expression of pluripotency-associated regulatory genes such as 
Prdm14, Dppa3, Zfp42, Pecam1, Nanog and SSEA1 in metastable ESC colonies, three 
different groups of ESCs can be recognized (Singer et al., 2014). One group expresses 
high levels of pluripotency related markers including Dppa3, and low levels of keratin 
and actins. The second group is highly positive for Oct4 and Sox2, but Dppa3 and 
Nanog levels are reduced. Finally, a third group expresses significant levels of 
differentiation related markers including cytoskeletal proteins (Kolodziejczyk et al., 
2015; Marks et al., 2012; Singer et al., 2014).  
1.2.3. Primed ESCs 
Primed ESCs correlate with ICM cells from late blastocysts (De Los Angeles et 
al., 2015). They grow in the presence of Activin, and bFGF, and have a unique 
epigenetic and transcriptional signature. Promoters of early lineage specification 
markers are enriched with activating histone modifications such as H3K4me3. In 
contrast, the promoters of pluripotency related markers are suppressed both by de 
novo DNA methylation and by an increase of H3K27me3 and H3K9me3 levels. One of 
the X chromosomes is inactivated (Guyochin et al., 2014). Expression of Oct4, Sox2 
and other pluripotency related factors is still characteristic for primed ESCs, even if 
the Oct4 genes is regulated by a different enhancer (Pan et al., 2002). Nanog 
expression is low and typical pre-implantation factors such as Dppa3 and Zfp42 are 
silenced. Genes related to differentiation such as Gata4, Gata6, Sox17, Otx2, and 
FGF5 become transcribed in colonies of primed ESCs (Iwafuchi-Doi et al., 2012; 
Kojima et al., 2014). 
1.3. Primordial germ cell-like cells  
In 2011, Mitinori Saitou´s laboratory introduced a new protocol for the 
differentiation of ESCs into primordial germ cell-like cells (PGCLCs) (Hayashi et al., 
2011). This protocol was unique because it involved an intermediate cell type, the 
epiblast-like cells (EpiLCs). These intermediate cells express low levels of primitive 
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endoderm marks such as Sox17 and Gata4/6 (Padua et al., 2014), and therefore they 
are different from epiblast stem cells (Hayashi et al., 2011). EpiLCs can be induced by 
BMPs into PGCLCs, which possess a transcriptional profile highly related to migratory 
PGCs in vivo (Saitou and Yamaji, 2012). PGCLCs have undergone an extensive 
epigenetic reprogramming, which includes the increase of H3K27me3 and a 
simultaneous decrease of H3K9me2 histone modifications (Hayashi et al., 2011). 
Thus, the in vitro differentiation of ESCs via EpiLCs into PGCCLs mimics closely the in 




Figure 2: Correspondence between embryonic stage and ESC categories. 
Naive ESCs correspond to the ICM of early blastocysts. These cells have low levels of 
suppressive histone modifications and DNA methylation. Metastable ESCs correspond to an 
ICM in mid blastocysts. They fluctuate characteristically between naive and primed status. 
Primed ESCs correspond to the ICM of late blastocysts. These cells are committed to 
differentiation and have stochastic expression of early lineage specification genes such as 
Gata4 and 6. PGCLCs correspond to PGCs are induced in egg cylinder stage embryo at the 
onset of gastrulation. 
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1.4. Double strand break (DSB) repair 
DNA damage can be induced by physical forces or chemical components. 
Cells possess a wide repertoire of mechanisms to respond to such defects, 
depending on the specific type of damage, and on parameters such as chromatin 
status (euchromatin, heterochromatin) or cell cycle phase. Double strand breaks 
(DSBs) are recognized by the MRN complex (Mer11, Rad50 and Nbs1), which acts as 
a platform for further proteins required for DSB repair (Lamarche et al., 2010). A key 
role is played by the ATM (Ataxia telangiectasia mutated) kinase, which 
phosphorylates H2AX and the mediator of DNA damage checkpoint protein 1 
(MDC1) (Alvarez-Quilon et al., 2014). The latter, recruits a number of other proteins 
including the two E3 ligases RNF8 and RNF168, which ubiquitinate histone H1, and 
H2A respectively (Thorslund et al., 2015; Zimmermann and de Lange, 2014). This 
initiates an opening of the chromatin at sites of damage, allowing the interaction 
with the DNA repair machinery (Zimmermann and de Lange, 2014). The two main 
pathways for DSB repair are non-homologous end joining (NHEJ) or homologous 
recombination (HR) (Fig. 3). Their choice strongly depends on the phase of the cell 
cycle, and thus the presence or absence of Cyclin-dependent kinase 1 (CDK1).  
 
1.4.1. Non-homologous end joining  
NHEJ is the dominant DSB repair pathway in the G1 phase, when there is no 
replicated DNA to be used as a template (Mao et al., 2008). Since the DNA ends are 
ligated after removal of one or two nucleotides, NHEJ is not precise and introduces 
mutations (Deriano and Roth, 2013). The chromatin at a DSB is characterized by 
three histone modifications, namely H4 di-methylated on residue K20, H2A 
ubiquitinated on K12, and H2AX phosphorylated on S139 (Baldock et al., 2015). The 
large protein 53BP1 recognizes these modifications via its Tudor, UDR and BRCT 
domains, respectively (Figure 4). It promotes chromatin relaxation, and RIF1 and 
Mad2l2 are downstream effectors (Boersma et al., 2015; Xu et al., 2015a). Together, 
these proteins inhibit DNA 5' end resection, and thus promote NHEJ while 
antagonizing HR. Mechanistically, NHEJ relies on heterodimers of the highly 
abundant Ku70 and Ku80 proteins which have a high affinity for DNA ends after a 
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DSB, but only if the 5' ends are not resected (Deriano and Roth, 2013). The 
Ku70/Ku80/DNA complex is first recognized by DNA-dependent protein kinase (DNA-
PKc), and then by the Artemis protein, which leads to DNA-PKc auto-phosphorylation 
and Artemis phosphorylation (Moshous et al., 2001). A conformational change then 
allows to bring the broken DNA ends close to each other, so that they can be joined 
by ligase IV and XRCC4 (Collis et al., 2005) 
1.4.2. Homologous recombination 
In the S/G2 phase of the cell cycle, DSBs are preferentially repaired by HR 
(Mao et al., 2008). Cdk1 phosphorylates CtIP, one of the early recruited proteins to 
the damage site, which then recruits breast cancer 1 (BRCA1) (Peterson et al., 2011). 
This complex inhibits the interaction of 53BP1/RIF1 and thus antagonizes NHEJ 
(Escribano-Diaz et al., 2013). Additionally, CDK1 activity is essential for DNA 5’ end 
resection by activation of Exonulease1 (Exo1) (Tomimatsu et al., 2014). Single-
stranded DNA is recognized by replication protein A (RPA) which is essential for 
recruitment of other factors and finally for HR (Moynahan and Jasin, 2010; Sung and 
Klein, 2006). 
 
Figure 3: ATM cascade. DNA damage response after DSB and the decision between HR and 




Figure 4: 53BP1 and RIF1 are recruitment of DSBs. For explanation see 1.4. Figure is taken 
from (Zimmermann and de Lange, 2014). 
 
1.5. The Mitotic arrest deficient 2-like protein 2 (Mad2l2)  
The Mad2l2 (Rev7) protein consists of 211 amino acids, adding up to a 
molecular weight of 24,334 Da. It is structurally related to the mitotic arrest-
deficient protein 2 (MAD2), with which it shares 26% identical and 54% similar amino 
acids. Mad2l2 has a protein-protein interaction sequence known as a HORMA (Hop1, 
Rev7 and Mad2) domain, and interactions with numerous, at first sight unrelated 
proteins were described (UniProtKB-Q9D752). However, postulated functions 
Mad2l2 in cell cycle control or transcription factor regulation mostly based on 
interactions with Cdc20, Cdh1, TCF4 have remained functionally unclear or 
contradictory (Chen and Fang, 2001; Chun et al., 2013; Hong et al., 2009; Iwai et al., 
2007). Much better understood is a role for Mad2l2 in DNA damage repair. Mad2l2 
was described as an accessory subunit of translesion polymerase ζ, forming a ternary 
complex with Rev1 and Rev3. Translesion DNA repair is a highly error-prone 
mechanism increasing the rate of mutagenesis significantly (Iwai et al., 2007). 
Mad2l2-deficient cells are hypersensitive to DNA damage induced by DNA cross-
linkers such as cisplatin (Niimi et al., 2014). The observed increase of γH2AX foci is 
catalyzed by one of the three kinases DNA-PK, ATM or ATR (Wang et al., 2005; Ward 
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and Chen, 2001). It indicates an accumulation of DSBs, which are not efficiently 
repaired in the absence of Mad2l2 (Cheung et al., 2006). 
Mad2l2 protein is not generally necessary for mouse development but it is 
specifically required for PGC development (Khalaj et al., 2014; Pirouz et al., 2013; 
Watanabe et al., 2013). Mad2l2-deficient PGCs are properly induced, but disappear 
shortly after, without undergoing the obligatory epigenetic reprogramming from a 
H3K9me2 to a H3K27me3 chromatin configuration (Pirouz et al., 2013). For the 
molecular function of Mad2l2 it was previously suggested that it would antagonize 
the methylation of H3 on the K9 residue via interaction with the methyltransferases 
Ehmt2 and Ehmt1 (Pirouz et al., 2013). On the other hand it was shown that Mad2l2 
binds and inhibits Cdk1, and thus might maintain methyltransferase Ezh2 in an active 
state, which would then result in the methylation of H3 on residue K27 residue 
(Pirouz et al., 2013). 
Mad2l2 is an essential factor for the stable maintenance of pluripotency of ESCs in 
LIF/Serum medium. Mad2l2-deficient ESCs heterogeneously express primitive 
endoderm markers such as Sox17 and Gata4, since the MAPK signaling pathway is 
hypersensitive and several of its components are misregulated. In these cells the 
Nanog promoter was occupied with a silencing epigenetically mark and the Gata4 
promoter had lost its bivalent status. In the absence of Mad2l2, a global increase of 
heterochromatin markers was observed (Pirouz et al., 2015). Expression of primitive 
endoderm markers were rescued by ERK signaling pathway inhibition, which, 
however, did not replace the epigenetic regulatory roles of Mad2l2 (Pirouz et al., 
2015).  
 
1.6. Aim of the thesis  
The aim of the submitted thesis was to understand the role of epigenetic 
programming and reprogramming in PGCs and ESCs, in comparison to related 
processes occurring in response to the damage of DNA. At the core of the work 
stood the Mad2l2 protein and its function in development and epigenetics. 
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2. Materials and methods 
If experiment procedure is not mentioned here, standard protocols and materials 
were applied as summarized in current protocols in molecular biology (Ausubel, 
2002). 
2.1. Polymerase chain reaction (PCR) 
DNA fragments were amplified by PCR. For each primer annealing 
temperature was identified by gradient PCR with respect to each primer melting 
temperature. Expansion time was calculated based on amplification size (1 min per 1 
kb). The GoTaq® DNA polymerase (Promega) was applied according to the 
instructions of the manufacturer. Materials are listed in Table 1. The amplification 
program (Table 2) was executed using the Mastercycler® Gradient (Eppendorf). 
 
Table 1. List of materials used for PCR  
Name Company Catalog number 
GoTaq G2 polymerase Promega M7841 
GoTaq G2 polymerase Promega M7822 
GoTaq G2 Green Master 
Mix 
Promega C1141  
PCR Nucleotide Mix Promega P1193 
Nuclease-Free Water Promega P1193 
dNTP Solution Mix Promega N0447S 
Nuclease-Free Water NEB M7841 
     
Table 2. Standard amplification program 
Step Number of cycles Temperature time 
1) Initial denaturation 1 94°C 2 min 
2) Denaturation 30-40 94°C 45 sec 
3) Annealing  55‐65°C 45 sec 
4) Elongation  72°C 1 min per 1kb 
5) Final elongation 1 72°C 19 min 
 
2.2. Reverse transcriptase – polymerase chain reaction (RT‐PCR) 
The QIAGEN® Omniscript kit (QIAGEN-205110) was used to make 
complementary DNA from RNA templates. The enzyme mix contains the Ominscript, 
10X RT buffer, dNTP mix, Oligo-dT primer, RNase inhibitor (Promega-N2511), and RT-
enzyme (Table 3). One µg isolated RNA was used for each reaction. Master Mix and 
 19 
templates were incubated in for 30 min at 37°C by the Mastercycler® Gradient 
(Eppendorf). 
 
Table 3. List of materials and final concentration for RT-PCR 
Component Volume Final Concentration 
10x Buffer RT 2 μl 1x 
dNTP Mix 2 μl 0.5 mM each dNTP 
Oligo-dT primer 2 μl 1 μM 
RNase inhibitor 1 μl 10 units (per 20 μl reaction) 
Omniscript 1 μl 4 units (per 20 μl reaction) 
 
2.3. Quantitative PCR (qPCR) 
Total RNA was extracted from LIF/2i expanded ESCs by RNeasy kit (Qiagen) 
according to manufacturer standard protocol. cDNA was synthesized as described 
earlier (2.2). For each reaction 25 ng cDNA, 10 mM primers, and 10 µl from KAPA 
SYBR® FAST qPCR Master Mix (KAPA biosystems-KK4600) were mixed. The 
amplification program (Table 4) was executed using the Biosystems 7300 Sequence 
Detection system. The expression levels based on Ct values after normalization with 
GAPDH. 
 
Table 4. Standard amplification program for qPCR 
Step Number of cycles Temperature Time 
1) Initial denaturation 1 95°C 3 min 
2) Denaturation 30-40 95°C 1-3 sec 
3) Annealing  55‐65°C 20 sec 
4) Elongation  72°C 20 sec 
5) Data acquisition 1 72°C 30 min 
  
Primers were designed by primer-blast tools from NCBI and amplification size was 








Table 5. List of RT-qPCR primers 
Name Sequence Tm 
Dnm3b-F  GCCAGACCTTGGAAACCTCA  59.89°C 
Dnm3b-R  GCTGGCACCCTCTTCTTCAT 60.03°C 
Wnt3-F  GCGTGGCCAACCTAACTCTT  60.61°C 
Wnt3-R  ATTCACGGGTGGCAGTCATT  59.96°C 
Sox17-F  CAGGGTCTGGCCTGAATGTT  59.96°C 
Sox17-R  GCTCTTTCCAGTCCCTGGTC  60.04°C 
Hoxb1-F  TCAGCCTACGACCTCCTCTC  60.11°C 
Hoxb1-R  CGGACACCTTCGCTGTCTTA  59.76°C 
Klf4-F  TACCCCTACACTGAGTCCCG  60.03°C 
Klf4-R  GGAAAGGAGGGTAGTTGGGC  60.03°C 
FGF5-F  CGGCTCGGAACATAGCAGTT  60.46°C 
FGF5-R  AATTTGGCTTAACACACTGGC  57.61°C 
Nanog-F  CACCCACCCATGCTAGTCTT  59.38°C 
Nanog-R  ACCCTCAAACTCCTGGTCCT  60.10°C 
Oct4-F  CTGAGGGCCAGGCAGGAGCACGAG  60.83°C 
Oct4-R  CTGTAGGGAGGGCTTCGGGACTT  60.87°C 
Sox2-F  TAGAGCTAGACTCCGGGCGATGA  64.27°C 
Sox2-R  TTGCCTTAAACAAGACCACGAAA  59.30°C 
Prdm14-F  CGGCTTCAACTTCACAGAGG  58.85°C 
Prdm14-R  AAGATGATTAGACCCAGAACTCTC  57.52°C 
Zfp42-F  TCCATGGCATAGTTCCAACAG  58.00°C 
Zfp42-R  TAACTGATTTTCTGCCGTATGC  57.12°C 
Gata6-F  GTCTCTACAGCAAGATGAATGG  56.60°C 
Gata6-R  CATAAGGTAGTGGTTGTGGTG  56.25°C 
Gata4-F  CCATCCAGTGCTGTCTGCTCT  61.12°C 
Gata4-R  ACTTTGCTGGCCCCCACGTC  65.46°C 
Gapdh-F  GTCGTGGAGTCTACTGGTGTC  59.80°C 
Gapdh-R  GAGCCCTTCCACAATGCCAAA  61.44°C 
Blimp1_Venus_F  ACTCATCTCAGAAGAGGATCTG  59.00°C 
Blimp1_Venus_R  CACAGTCGAGGCTGATCTCG  66.30°C 
Dppa3_ECFP_F  CGACTCTAGATCATAATCAGCC  59.40°C 
Dppa3_ECFP_R  TAAGATACATTGATGAGTTTGGAC  58.60°C 
Dppa3-F  CGTCCTACAACCAGAAACAC  59.70°C 
Dppa3-R  CTGCTCAATCCGAACAAGTC  62.40°C 
Mad2l2-F  GTTGCCTTGAGTCCCTACAG  61.30°C 
Mad2l2-R  TCCACATCGTTCTTCTCCAG  62.90°C 
Tet1-F  CAGACCCAGCATCAATCCTC  64.70°C 
Tet1-R  TACCTCCATCACAGTCACAG  58.70°C 
Tet2-F  CGATGTTTCAGAATCAGATACTCC  62.60°C 
Tet2-R  TCTCCGATATACCCATTTAGCA  62.10°C 
Tet3-F  GACTGTGCTCTCAACTACCT  56.00°C 
Tet3-R  TTCTCCATACCGATCCTCCA  64.40°C 
Mad2l2_Genotyping P1  GCTCTTATTGCCTTGACATGTGGCTGC  65.00°C 
Mad2l2_Genotyping P2  GGACACTCAGTTCTGGAAAGGCTGG  65.00°C 
Mad2l2_Genotyping P3  CTGCAGCCCAATTCCGATCATATTCAATAAC  65.00°C 
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2.4. Cell culture 
2.4.1- MEF (isolation, expansion, freezing, thawing) 
Mating was arranged between two Mad2l2+/- male and Mad2l2+/- female 
animals and pregnancy time was identified by the formation of vaginal plaque 
(Pirouz et al., 2015). Pregnant females on E13.5 were sacrificed by exposing to 
carbon dioxide. Uterine horns were removed from body and placed into a 50 ml 
falcon tube containing PBS. Each embryo was separated from placenta and 
transferred to distinct wells. Brain and dark red organs were removed and remains 
transferred in to fresh PBS filled plates. Tissue was suspended with 2 ml of trypsin-
EDTA (Gibco 25300-096) and incubated with gentle shaking at 37°C for 15min. For 
further dissociation, cell suspension was transfered from a syringe with gage 18 
needle. Trypsin was neutralized with DMED medium supplemented with 10% FBS 
(Table 6). 
 
Table 6. List of materials for MEF culture 
Name Company Catalog Number 
DMEM (High Glucose) Gibco 41966-052 
FBS Biochrom S0115 
L-glutamine Gibco, 25030-024 
Penicillin-streptomycin Gibco, 15140-122 
DMSO Sigma D2650 
Knockout DMEM Gibco 10829-018 
Knockout Serum Replacement Gibco 10828-028 
Non-Essential Amino Acids Gibco 11140-035 
beta-Mercapto–ethanol Sigma M7522 
DNase I Sigma D4527 
Mitomycin C Roche 10107409001 
Basic Fibroblast Growth Factor PeproTech 100-18B 
Gelatin Sigma G9391 
0.05% Trypsin-EDTA Gibco,  25300-054 
 
2.4.2. Embryonic stem cells 
 
ESCs were cultured by a standard protocol in DMEM: 10%serum and LIF 
(1000 u/ml) on inactive MEFs (Ying et al., 2008). Wild-type and Mad2l2-deficient 
ESCs establishment and was previously established by Pirouz et al., 2015 (Pirouz et 
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al., 2015). ESCs were cultured by a standard procedure in N2B27 medium with 2i 
(PD0325901, 0.4 μM: Stemgent, San Diego, CA; CHIR99021, 3 μM: Stemgent) and LIF 
(1000 u/ml) on gelatin-coated plate (Pirouz et al., 2015; Ying et al., 2008). BVSC ESCs 
were donated by Mitinori Saitou (Ohinata et al., 2008). These ESCs have eCFP and 
mVenus reporter between Dppa3 promoter and transcription starting site and 
between Prdm1 (formerly Blimp1) and transcription starting site, respectively. H2AX, 
DNA-PK and ATM deficient ESCs were donated by Frederick W. Alt (Bassing et al., 
2003; Gao et al., 1998; Zha et al., 2008). Growth condition for these cells was equal 
with wild-type ESCs.  
 
2.5. Differentiation of ESCs 
2.5.1. EpiLCs 
This protocol was previously described by Hayashi et al., (Hayashi et al., 2011) 
6-well pates were coated with human plasma fibronectin (16.7 μg/ml) and incubated 
overnight at 37 C. ESCs (2.0 × 105) were seeded on the coated palates in N2B27 
medium containing activin A (20 ng/ml), bFGF (12 ng/ml), and KSR (1%) and the 
medium was changed every day. 
2.5.2. PGCLCs 
This protocol is a modified version of Hayashi et al (Hayashi et al., 2011). 
EpiLCs were trypsinized and 2.0 × 103 were counted and plated on a low-cell-binding 
U-bottom 96-well plate in a serum-free medium (GK15; GMEM [Invitrogen] with 15% 
KSR, 0.1 mM NEAA, 1 mM sodium pyruvate, 0.1 mM 2-mercaptoethanol, 100 U/ml 
penicillin, 0.1 mg/ml streptomycin, and 2 mM L-glutamine) in the presence of the 
cytokines BMP4 (500 ng/ml; Peprotech), LIF (1000 u/ml; Invitrogen), SCF (100 ng/ml; 
Peprotech), and EGF (50 ng/ml; R&D Systems). After 24 h, aggregates were shacken 
gently for elimination of death cells. Two days after PGCLC induction cells were 
transferred to a five-centimeter plate in the old medium. Aggregates were cultured 
in five-centimeter plates for four more days.  
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2.6. Cell manipulation 
2.6.1. Inhibitor and cisplatin experiments 
 ESCs cells were grown in LIF/2i medium to 40% confluency in 6-well plates. 
Inhibitors were mixed with fresh LIF/2i medium (Table 6). ESCs were culture for 
defined times (Table 7) under standard growing conditions, and ESCs were harvested 
after washing with PBS.  
Table 7. List of used inhibitors 
Name Cat.Num Final concentration Treatment time 
Trichostatin A T8552 SIGMA 250 nM, 4000x 8h 
SAHA SML0061 SIGMA 10 um, 1000x 8h 
5-Azacytidine A2385 SIGMA 70 uM, 1000x 48h 
GSK126 500580  Millipore 10 mM, 5000x 24h 
BIX 01294 B9311 SIGMA 4.1 mM 4000x 24h 
KU-55933 SML1109 SIGMA 10 uM, 1000x 24h 
VE-821 SML1415 SIGMA 5 uM, 1000x 24h 
NU-7441 CAS 503468-95-9 5 uM, 1000x 24h 
 
2.6.2. Cell transfection 
Cells were transfected with Lipofectamine 2000 (cat. 11668500) based on 
theprotocol recommended by the manufacturer. CMV-GFP-Md2l2 plasmid was 
purified by phenol extraction and ethanol precipitation. Details about plasmid 
werepublished previously (Pirouz et al., 2013).  
2.7. ABC staining 
  Cryo-section slides were prepared according to 2.12. Slides were washed 3 
times for 5 minutes with PBS. Samples were encircled with fat pen and covered with 
block solution for 30 minutes at RT. Dppa3 antibody was applied and incubated 
overnight at 4 °C.  
 




0.1M phosphate, 0.15M NaCl, pH 7.5 
Blocking Buffer Add 3 drops of normal serum from the ABC Staining Kit to 10 mL of PBS. 
Alternatively, 1% BSA in PBS may be used 
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Primary Antibody Dppa3 (Santa Cruz, cat no. sc-19878) 
Biotinylated Secondary 
Antibody 
Add 3 drops (135μL) of normal serum and 1 drop (45μL) of the 




Prepare reagent 30 minutes before use (see Step 5). Add 2 drops (90μL) 
of Reagent A to 10mL of PBS followed by 2 drops (90μL) of Reagent B. 
Immediately mix the solution and allow 30 minutes for the complex to 
form. 
Detection Substrate Thermo Scientific Metal Enhanced DAB Substrate Kit (Product No. 
34065) 
 
Slides were washed 3 times for 10 minutes with PBS. The biotinylated secondary 
antibodies were applied and incubated for 30 minutes at RT. Slides were washed 3 
times for 10 minutes with PBS. The tissue sections were incubated with the ABC 
Reagent for 30 minutes. Slides were washed 3 times for 10 minutes with PBS (Table 
7). 
 
2.8. Immunofluorescence staining 
ESCs were cultured on chamber slides (Nuc Lab-Tek) to reach the desire 
dconfluency. Cells were washed 3 times for 5 minutes with PBS, and rinsed with NP-
40 0.1 to 0.2% in PBS for 10 min for permeabilization. Washing steps were repeated 
by PBT (1x PBS 0.1% Tween 20). Chamber slide walls were removed and samples 
were surrounded by fat pen. Cells were covered with block solution for 60 minutes 
at RT (1% BSA, 22.52 mg/ml glycine in PBT). First antibody was applied and incubated 
overnight at 4 °C (Table 9). Slides were washed 3 times for 10 minutes with PBT. 
Secondary antibody was applied and incubated for 60 minutes at RT. Slides were 
washed 3 times for 10 minutes with PBS. Samples were mounted with 
VECTASHIELD® Mounting Medium with DAPI (Vector Laboratories). The coverslips 
were sealed using nail polish. The sample was documented by confocal microscopy 
(Leica SP3). 
To find the best antibody against Mad2l2 different antibodies were 
tested.(Table 10) Test procedure had two steps. First recognition of antigen in a 
native form and wild-type and knockout cells were subjected to 
immunofluorescence staining. Secondly, antibody capability in recognition of 
denatured protein was checked by western blot. Just one antibody* passed both 
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tests. Results from this antibody were in contradiction with some previously 
published reports (Medendorp et al., 2009; Weterman et al., 2001). 
 
Table 9. List of antibodies 
Name Company Catalog number Concentration 
Anti pH3 Cell Signaling  9706 1: 200 
Anti Cyclin B1 Santa Cruz sc-245 1: 100 
Anti Sox2 Millipore  AB5603 1: 200 
Anti Oct4 Abcam  ab18976 1: 200 
Anti Nanog Abgent   AM1486b 1: 200 
Anti Erk Cell Signaling 9102 1: 100 
Anti pERK Cell Signaling 9101 1: 100 
Anti ϒH2AX Millipore 05-636 1: 100 
Anti TFAP2C Santa Cruz sc-53162 1: 100 
Anti Dppa3 Santa Cruz sc-19878 1: 100 
Anti pChk2 Cell Signaling  2661S 1: 100 
Anti Ki67 Abcam ab15580 1: 200 
Anti H3K9me2 Abcam  ab6002 1: 200 WB 1: 2000 
Anti H3K27me3 Abcam  ab8580 1: 200 WB 1: 2000 
Anti-Rabbit (HRP) Abcam ab6721 WB 1: 10000 
Anti-mous (HRP) Abcam ab97046 WB 1: 10000 
Alexa Fluor 488 α-m Thermo Fisher Z25002 1: 1000 
Alexa Fluor 594 α-m Thermo Fisher Z25007 1: 1000 
Alexa Fluor 647 α-m Thermo Fisher Z25008 1: 1000 
Alexa Fluor 488 α-r Thermo Fisher Z25302 1: 1000 
Alexa Fluor 594 α-r Thermo Fisher Z25307 1: 1000 
Alexa Fluor 647 α-r Thermo Fisher Z25308 1: 1000 
STAR 635 α-r Abberior 2-0032-051-9* 1: 100 
STAR 580 α-m Abberior 2-0032-051-9* 1: 100 
Protein A/G Santa Cruz sc-2003 50 ul 
Anti AcH4 Millipore 06-946 WB 1: 10000 
Anti RNF168 Santa Cruz sc-101125 1: 100 
Anti 53BP1 Santa Cruz sc-22760 1: 100 
Anti p53BP1 Santa Cruz sc-135748 1: 100 
Anti SSEA1 R&D FAB2155P-025 1: 200 
Anti integrin β3 R&D FAB2266A 1: 200 
* A STED microscopy dual secondary antibody kit 
 
Table 10. List of Mad2l2 different antibodies 
Name Company Catalog number Concentration 
Anti Mad2l2* Abcam ab180579 1: 200 WB 1: 1000 
Anti Mad2l2 Abcam ab3630 WB 1: 1000 




2.9. TUNEL assay 
For the TUNEL assay, TdT in Situ Apoptosis Detection Kit – Fluorescein (R&D 
system, ca.no:4812-30-K) was used. ESCs were cultured on chamber slides (Nuc Lab-
Tek) to reach the desire confluency. Samples were placed in 1X PBS for 10 minutes at 
RT. 100% ethanol was used for fixation after rinsing with PBS for rehydration. The 
slide wall was removed and the sample was surrounded by fat pen. Slide was 
covered with 50 μl of Proteinase K Solution 30 min at RT. Slide was washed 2 times 
in deionized water 2 min and immersed in 1X TdT Labeling Buffer 5 min. Samples 
were covered with 50 μl of Labeling Reaction Mix and were incubated for 1 h at 37 
°C. Labeling was stopped by 1X TdT Stop Buffer 5 min at RT. Washing step was 
repeated 2 times by 1X PBS for 5 minutes each at room temperature. Slide was 
covered with 50 μl of Strep-Fluor solution for 20 min at RT. After another washing 
step and documented by confocal microscopy (Leica SP3).  
2.10. Metaphase chromosome spreads 
Double thymidine Block: ESCs were culture in N2B27 medium supplemented 
with LIF/2i to approximately 40% confluency. 20ul of Thymidine (1 mg per 50 ml 
medium) was added to each 1ml of culture media. Cells were incubated for exactly 
19 hours at 37 °C. Medium was removed and cells were washed with 1X PBS 3 times. 
Fresh medium was used and cells were incubated for 9 hours. Again 20ul of 
Thymidine was added to each 1ml of culture media and cells were incubated for an 
additional 16 hours. Medium was removed and cells were washed with 1X PBS 3 
times. Fresh medium was added and cells were cultured for 4-5 h, when most had 
entered metaphase. 
 
Table 11. List of materials for chromosome spreads 
Name Company Catalog Number 
Thymidine Sigma 15212-012 
HBSS Buffer Gibco 24020-117 
0.5% Trypsin EDTA 10x Gibco 15400-054 
Permount Fisher Scientific SP15-100 
Buffer Tablets "GURR" Gibco 10580-013 
Methanol Caledon Laboratory Chemicals 6700130 
Glacial Acetic Acid Krackeler Scientific Inc. 11-9508-05 
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Preparation of slides: Cells gently were washed in 2 ml of HBSS Buffer and 
dissociated by trypsin after 2 min incubation at 37 °C. Cell suspension was 
transferred into 15 ml conical tubes and trypsin was neutralized with MEF medium. 
Tubes were centrifuged at 200 x g for 10 min and supernatant was removed. Pellet 
was dissolved in 10 ml of 0.075 M KCl which has been pre-warmed to 37 °C for 10 
min. Tube was centrifuged at 200 x g for 5 min at 25 °C. 5 ml of fresh Carnoy's 
Fixative (3:1 ratio of methanol:glacial acetic acid) was add to the cells while 
vortexing. Then 5 ml of fixative was added for a total of 10 ml. Tube was centrifuged 
at 200 x g for 5 min. Cells were resuspended in 5 ml of fixative to each tube. Tube 
was centrifuged at 200 x g for 5 min. Condensed cell suspension was dropped on 
slide and tilted at an angle of about 45°. A large drop of fresh Carnoy's Fixative was 
added to the slide. Slide was dried with a paper from one direction, and was covered 
with VECTASHIELD® Mounting Medium with DAPI (Vector Laboratories). The 
coverslips were sealed using nail polish. The samples were monitored and 
documented with the BX‐60 fluorescence microscope (Olympus). 
2.11. Dot blot 
DNA was isolated by standard protocol (Sambrook and Russell, 2006) and 
was precipitated by 70% ethanol. Precipitated DNA was dissolved in deionized water 
and denatured at 99 °C. Samples were cooled on ice, spinned down, and neutralized 
with 0.1 vol of 6.6 M ammonium acetate. 50 ng DNA was dropped on the membrane 
and air-dried, while the membrane was placed on a filter. DNA was cross-linked to 
the membrane by UV. The membrane was blocked by blocking solution 10% milk, 1% 
BSA, PBT (1xBPS + 0.1% Tween-20), then washed by PBT 3 times at RT, and 
incubated with primary antibody against 5mC (1:1000) overnight at 4 °C. The 
membrane was washed by PBT 3 times at RT and incubated with HRP secondary 
antibody (1:10000 in blocking solution) for 60 min at RT. Washing step was repeated 
for one more time, and the membrane was developed by Pico chemiluminescent 
substrate (Thermo Scientific). 
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2.12. Western blotting  
Western blot procedure is described in details in Bio-rad website (www.bio-
rad.com). Cells at the desired confluency were washed with PBS three times and 
harvested by RIPA (radio immune precipitation assay) buffer supplemented with 
protease inhibitor. Protein concentrations were measured by Bradford analysis. 
Samples were mixed with 4X protein loading buffer, and were incubated for 5 min at 
99 C. Equal amounts of proteins were loaded on a precast 12% SDS-Gel (bio-rad). 
Electrophoresis was started for 5 min at 50 v and voltage was increased to 150 V for 
1h. After this step, the gel was blotted to on the nitrocellulose membrane. The 
membrane was blocked by blocking solution 10% milk, 1% BSA, PBT (1xBPS + 0.1% 
Tween-20). PBT was used for washing step, 3 times at RT. Consequently, the 
membrane was incubated by primary antibody over night at 4 °C. The washing step 
was repeated, and the membrane was incubated with HRP secondary antibody 
(1:10000 in blocking solution) for 60 min at RT. This procedure was followed by a 
final washing step (PBT, 3 times at RT). The membrane was developed by Pico 
chemiluminescent substrate (Thermo Scientific). 
 
2.13. Cryosectioning 
Aggregates were harvested after PGCLCs induction and they were washed 
three times with PBS at room temperature for 5 min. Samples were fixed in 4% 
paraformaldehyde (PFA; 7.4 pH) for 2 hours at RT. PFA solution was removed and 
samples were rinsed with PBS. To prevent freezing damages, cells were dehydrated 
by sucrose solutions steps. First 10% sucrose solution was used, and the sample was 
floated in the solution for 15 min. The same procedure was repeated for 20% and 
30% Sucrose solutions, respectively. Finally, 30% the solution was removed three 
times and replaced with fresh 30% sucrose. Samples were removed from sucrose 
solution and placed on the bottom of the bottom of the chamber. Remainins 
solution was removed by Whatman paper as much as possible. The Chamber was 
filled with tissue-tek, and the block was frozen down on dry ice. Blocks were 
sectioned by a cryo-microtome and sections were stored frozen in –80 °C. 
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2.14. STED microscopy 
This procedure is a modified version of the previously published protocol 
(Revelo et al., 2014). p-toluenesulfonic acid monohydrate (Sigma-Aldrich) and 2,4,6-
Tris[bis(methoxymethyl)amino]-1,3,5-triazine (melamine) was solved in water, and 
shaken for 2h at RT. Immunostained cells were mixed with resin and a BEEM capsule 
(BEEM, Inc.). The mounted sample was put in a jar containing silica overnight at RT 
to allow penetration of melamine into the cells. The box was then heated to 40°C for 
24 h. The BEEM capsule was re-filled to the top by Epon resin (EpoFix kit; Struers). 
The samples was heated to 60°C for 48 h. Melamine blocks were cut into thin 
sections with an ultramicrotome (EM UC6; Leica). Sections were documented by 
STED microscope (TCS SP5; Leica). STED microscopy was performed in collaboration 
with Dr. Dirk Kamin, Department of Nano Biophotonics, Max Planck Institute for 
Biophysical Chemistry, Goettingen. STED microscopy increases the resolution by 
minimizing the area of illumination at the focal point. Therefore by this technique 
close points can be distinct from each other beyond the confocal microscope ability.  
 
2.15. Immune precipitation 
The protocol is described in abcam company website in details 
(www.abcam.com). Cells were cultured to the desired confluency in appropriate 
medium. 100 μl denaturing lysis buffer was used for 0.5 to 2 x 107 cells and was 
mixed by vortexing briskly for 2 to 3 sec at maximum speed. For further 
homogenization, samples were sonicated by Diagenode sonicator for 20 cycle 30s 
pulse and 30 rests in high power. 50 μl of normal serum was added to 1 ml of 
lysated, and Incubated for 1 hr on ice. 100 μl of protein A/G bead was added to the 
lysate. This suspension was incubated for 30 min at 4°C with gentle agitation. Beads 
were collected by centrifugation at 14,000 x g at 4°C. 10 µl of primary antibody was 
added to lysis buffer and sample were incubated over night at 4°C. Pre-cleaned 
protein A/G beads were added to sample and were incubated for 1 h at 4°C. Beads 
were collected by centrifuge at 1,000 g for 2 min at 4°C and supernatant was 
discarded. Beads washed by PBS or lysis buffer 3 times 5 min at 4°C.  
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Table 12. RIPA buffer  
Name Final concentration 
Tris HCl pH 8 50 mM 
NaCl 150 mM 
NP-40 1% 
Sodium deoxycholate 0.5% 
SDS 0.1% 
 
Table 13. Washing buffer 
Name Final concentration 
Tris HCl pH 7.4 10 mM 
EDTA 1mM 
EGTA pH 8.0 1mM 
NaCl 150mM 
Triton X-100 0.2mM 
 
Beads were collected by centrifuge at 1,000 g for 2 min at 4°C and supernatant was 
discarded. 50 µl of beads were eluted in 50 µl of 2X SDS buffer without DTT for 10 
min at 50°C. 100 mM DDT was added to sample. Sample boiled for 5 min at 99°C. 
 
2.16. Cell fractionation 
  This protocol is modified version of a previously published protocol (Carey 
and Smale, 2007). 108 cells were pelleted at 300g at 4 °C for 10 min in a centrifuge at 
4°C. Supernatant was discarded. Cell pellets were washed with 10 ml of ice-cold 1X 
PBS, and cells pelleted at 300g at 4 °C for 10 min in a centrifuge. Cell pellets were 
suspended in 5 ml of ice-cold NP-40 lysis buffer for 5 min. Nuclei were pelleted at 
120g at 4 °C for 10 min. The supernatant was collected as the cytoplasmic fraction. 
Nuclei were washed with 2.5 ml of MNase digestion buffer. Nuclei were pelleted at 
120g at 4 °C for 10 min. Supernatant was collected as the nucleoplasmic fraction. 
Samples were sonicated by Diagenode sonicator for 20 cycle 30s pulse/30s rest in 
high power. 
 
Table 14. NP-40 lysis buffer: 
Name Final concentration 
Tris HCl pH 7.4 10mM 







Table 15. MNase digestion buffer: 
Name Final concentration 






2.17. Flow cytometry 
Cells were trypsinized and pellets were washed in ice cold PBS 3 times. Cells 
were fixated with using pre cooled methanol (-20 °C) and incubated for 5 min at -20 
°C. Cells were washed 3 times for 5 minutes with PBT (1x PBS 0.1% Tween 20.). The 
cell pellet was resuspended in block solution for 60 minutes at RT (1% BSA, 22.52 
mg/ml glycine in PBST). First, antibodies were applied and incubated overnight at 4 
°C. Slides were washed 3 times for 10 minutes with PBS. Secondary antibody was 
applied and incubated for 60 minutes at RT. Slides were washed 3 times for 10 
minutes with PBS. Sample was read by accuri-6000 machine from BD. 
2.18.1. Chromatin immunoprecipitation  
 
Chromatin immunoprecipitation was performed base on two published protocols 
(Adli and Bernstein, 2011; Dahl and Collas, 2008).  
 
2.19. Bioinformatic analysis 
2.19.1. For RNA-seq data reanalysis workflow 
Fastq files were analyzed for quality (fastx_toolkit) and trimming 
(fastx_toolkit). Alignment and removing duplications: bowtie for illumine was used 
for fastq file alignment based on mm10 genome reference. SAM file was converted 
to BAM file and duplicated sequences and enriched sequences from PCR were 
removed by RmDup version 2.0.0. Deeptools analyzed correlation between BAM 
files. Genes with different expression was measured via two independent methods 
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(Cuffdiff and deseq2). Data were visualized by Visualization-Bioconductor package 
for R (version 3.2.2) Gene expression profile were visualized base on their position 
on genome by cuff-diff. 
2.19.2. ChIP-seq 
Fastq files were analyzed for quality (fastx_toolkit) and trimming 
(fastx_toolkit). Alignment and removing duplications: bowtie for illumina was used 
for fastq file alignment based on mm10 genome reference. SAM file was converted 
to BAM file and duplicated sequences and enriched sequences from PCR were 
removed by RmDup version 2.0.0. Deeptools analyzed correlation between BAM 
files. Reference genome was made by merging of Gff3 8 columns annotated files and 
BAM files (mm10). Merged file in combination with INPUT file was used for peak 
calling by MACS (ver 2.2.2). Significant peak were annotated and searched for motif 
enticement. MeDIP-seq data was analyzed by MEDIPS. Gene expression profile was 




3.1. The in vitro differentiation of ESCs towards germ cells  
To evaluate the potential of Mad2l2-deficient ESCs to differentiate into 
PGCLCs, a well-established and characterized protocol was applied (Hayashi et al., 
2011). As an endogenous transgenic marker Oct4 expression was assessed by using 
the GFP reporter knock in ESC line "OG2" (Wu et al., 2013). This line expresses Oct4 
under control of the distal enhancer, which is active in ESCs, but not after 
differentiation into EpiLCs, where it would normally be driven from the proximal 
enhancer. One day after the induction of differentiation in EpiLCs medium, the 
morphology of ESCs had changed significantly. Colonies now grew as monolayers, 
and no longer in the typical dome-shape of ESCs (Figure 5). The nuclear-cytoplasmic 
ratio was higher, and boundaries between the cells were clear. GFP expression was 
heterogeneous and low, but still clearly visible (Figure 5, D1). After 48 hours wild-
type cells had become confluent, and GFP expression was not detectable (Figure 5, 
D2). All cells were again GFP positive on the first day after aggregate formation (3 
days after induction of differentiation), but during the next two days GFP expression 
became limited to distinct areas of the aggregates (Figure 5, D3-5). These signals 
were brighter than the GFP noise levels on the first day. The morphology Mad2l2-
deficient cells differed significantly from control cells five days after aggregate 
formation (Figure 5, D7). In differentiating wild-type cells the small areas with GFP 
positive cells expanded dramatically under the influence of BMP4. In contrast, 
Mad2l2-deficient aggregates lost their GFP expression gradually, and just a few Oct4-
GFP spots were detectable on D8 (Figure 5). To study the morphology of GFP-
positive cells, D6 aggregates were fixed and analyzed by confocal microscopy. Wild-
type Oct4-positive cells grew in close contact, and formed coherent colonies close to 
the aggregate surface. In contrast, Mad2l2-deficient cells grew separately, and were 
located closer to the inside of the aggregates (Figure 6). Taken together, the 
development of Mad2l2-deficient ESCs into PGCLCs appeared strongly compromised 





Figure 5: Differentiation of ESCs via EpiLCs into PGCLCs.  
In D1 and D2 days, cells were cultured on a 2 dimensional surface, and from D3 to D8 cells 
were cultured in an aggregate form (3 dimensional cultures). Note that GFP is drastically 
downregulated in both wild-type and mutant EpiLCs (D2). It then returns in wild-type 




Figure 6: Colony morphology of differentiating cells growing in PGCLC inducing conditions.  
Localization of GFP-positive cells in wild type and Mad2l2-deficient cell aggregates. Dashed 
line indicates aggregate. Bar= 200 μm (left) and 50 μm (right). 
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3.1.1 Mad2l2-deficient EpiLCs resemble wild-type EpiLCs  
 The doubling time and number of mitotic EpiLCs were measured in order to 
compare general growth parameters of wild-type and mutant cells. Equal number of 
ESCs (n=200.000) were seeded onto tissue culture dishes in EpiLCs medium, and 
counted after 48 h. In the control group, around 25.000.000 (±200.000) cells were 
counted, indicating a doubling time of 13.76 h. The number of Mad2l2-deficient cells 
was significantly lower (around 1.800.000), indicating a doubling time of around 
15.14 h (Figure 7a).  
 To confirm a lower proliferation rate of Mad2l2-deficient EpiLCs, they were 
stained with antibody against pH3, demarcating cells in mitosis, and samples were 
analyzed by flow cytometry. About 1.2 percent of wild-type cells were pH3 positive, 
as compared to 0.5 percent of mutant cells (Figure 7b). Altogether, these data show 




Figure 7: Proliferation of EpiLCs is decreased in the absence of Mad2l2 
(a) Cell number determination indicates a slight decrease in the doubling time of Mad2l2-/- 
cells. (b) Less mutant cells are in mitosis at a given time. 
 
 As a first indication for a successful transition from naive to primed 
pluripotency the downregulation of the OG2 construct was checked under the 
fluorescence microscope. Regardless of the genotype GFP expression vanished 
within 2 days of growth in EpiLC medium. EpiLCs normally do not express primitive 
endoderm (PE) markers, a prerequisite for induction of PCLCs. The expression of 
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naive ESC markers (Klf4), EpiLCs markers (Dnmt3b, Wnt3) and PE markers (Gata4, 
Gata6 and Sox17) was evaluated by RT-PCR. The absence of Klf4 and the 
simultaneous increase of Dnm3b and Wnt3 RNA levels confirmed the transition from 
a naive to a primed state for both genotypes (Figure 8). In contrast, the PE markers 
were already considerably active in mutant ESCs before induction. This reflects the 
mutant cells (Pirouz et al., 2015), and may already indicate problems for the further 




Figure 8: RNA expression analysis of ESCs and EpiLCs markers in both wild-type and 
Mad2l2-deficient groups.  
Note the characteristic expression of Klf4 in ESCs, and Wnt3 in EpiLCs. The Gata4/6 RNAs in 
mutant ESCs indicate that differentiation into PE is not properly blocked predict problems 
for a later development into PGCLCs. 
 
 The expression of Sox2, Nanog, Oct4 (pluripotency related markers), FGF5, 
Dnmt3b, Wnt3 (EpiLCs markers), Gata4 and Gata6 (epiblast stem cell markers) was 
measured by quantitative RT-PCR before and after differentiation (D0-D2) (Figure 9). 
The linear expression of Oct4 mRNA and the simultaneous downregulation of Oct4-
GFP proved that the OG2 transgene was under control of the proximal Oct4 
enhancer. The downregulation of Nanog and Sox2 was in agreement with a previous 
report (Hayashi et al., 2011). Upregulation of EpiLC markers and downregulation of 
epiblast stem cell markers showed that Mad2l2 knockout ESCs differentiated into a 
primed state, which differed from epiblast stem cells by suppression of Gata4 and 
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Gata6. Wnt3 expression was higher in knockout ESCs. However, the expected raise 
after differentiation to EpiLCs was not observed in both groups. In conclusion, 
Mad2l2-deficient EpiLCs resembled closely their wild-type counterparts, except for 




Figure 9: Expression of marker genes in wild-type and Mad2l2-deficient ESCs and EpiLCs. 
There was no significant difference between wild-type and knockout cells. Fold changes 
were calculated by the delta-delta Ct method (Schmittgen and Livak, 2008). 
 
3.1.2 The differentiation of ESCs under PGCLC-inducing conditions in 
the presence or absence of Mad2l2 
 To quantify the differentiation Mad2l2-deficient ESCs into PGCLCs, Oct4-GFP 
positive cells were analyzed by flow cytometry. Three groups of cells with high, 
intermediate and low/absent levels of GFP were identified. After six days of 
differentiation approximately 70% cells expressed Oct4-GFP at the same level of 
ESCs, 10% had intermediate levels, and 15% cells were negative (Figure 10). In the 
Mad2l2-deficient group, the number of Oct4-GFP positive cells was lower (around 
30%), and the number of intermediate cells significantly higher. These data indicated 





Figure 10: Flowcytometry analysis of differentiation into PGCLCs.  
a) Orange: GFP negative cells, blue: cells with weak GFP expression, purple: GFP positive 
cells.  
b) Bar diagram indicating the number (percent) of cells per gate.  
 
 In vivo developing PGCs arrest the cell cycle on E9 in the G2 phase, a pause 
apparently correlated or essential for their epigenetic reprogramming (Seki et al., 
2007). It was previously shown that Mad2l2-deficient cells do not stop, and do not 
reprogram in the G2 phase of the cycle (Pirouz et al., 2013). In order to test the 
behavior of Mad2l2-deficient cells differentiating in vitro, they were analyzed by 
immunofluorescence for the subcellular localization of Cyclin B1, which is normally 
detected in the cytoplasm at the G2 phase, and moves into the nucleus upon the 
beginning of mitosis (Hochegger et al., 2008). On D8 around 58.5 % of wild-type 
Oct4-GFP positive cells were in the G1 phase of the cell cycle, 4.5 % in mitosis, and 
37 % in G2 (Figure 11). The percentages of both mitotic (0.9 %) and G2 cells were 
decreased drastically in Mad2l2-deficient cells (Figure 11). This finding was in 
agreement with in vitro findings and shows that Mad2l2-deficient PGCLCs do not 





Figure 11: Mad2l2-deficient GFP positive cells do not arrest in the G2 phase.  
a) Immunofluorescence staining with antibody against Cyclin B1 (red). Cells with cytoplasmic 
expression of cyclin B1 (arrow) are in G2, cells with nuclear expression in M, and negative 
cells are in other cell cycle phases. b) Quantification of immunofluorescence staining: Green, 
red and blue colors show number of cells in G2, M and other cell cycle phase, respectively. c) 
Significantly more wild-type cells are in the G2 phase. Bar = 10 µm.  
 
 The TUNEL assay was used to check for apoptosis in D8 aggregates. Apoptotic 
cells were limited to GFP negative cells in the wild-type cells aggregate. However, in 
differentiating mutant cells apoptosis was equally distributed between GFP-positive 
and -negative cells (Figure 12). This indicates an elimination of Mad2l2-deficient cells 
during their differentiation into PGCLCs. It confirms observations made on 
differentiating PGCs in vivo (Khalaj et al., 2014; Pirouz et al., 2013). 
 In vivo, PGCs reactivate many pluripotency related transcription factors, and 
at the same time suppress the Erk signaling pathway, which positively regulates 
somatic cell differentiation (Kimura et al., 2014). In principle reactivation of Oct4, 
Nanog and Sox2, and suppression of Erk occurred in the Oct4-GFP positive, even if 
the numbers of GFP-Oct4 positive cells are lower in Mad2l2-deficient aggregates 
(Figure 13). Immunofluorescence analysis revealed that the Erk protein was 
expressed equally, but that the phosphorylated Erk was considerably lower in the 
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Oct4-GFP positive cells (Figure 13). Altogether, Mad2l2 protein appeared not to be 
essential for reactivation of core factors, and suppression of Erk.  
 
 
Figure 12: Increased apoptosis in Mad2l2-deficient, GFP positive cells.  
TUNEL positive, GFP-positive areas within D8 aggregates are enriched (dash line). Note the 
high numbers of apoptotic cells in the absence of Mad2l2 in GFP positive cells. Bar = 25 µm.  
 
 In vivo, PGCs reactivate many pluripotency related transcription factors, and 
at the same time suppress the Erk signaling pathway, which positively regulates 
somatic cell differentiation (Kimura et al., 2014). In principle reactivation of Oct4, 
Nanog and Sox2, and suppression of Erk occurred in the Oct4-GFP positive, even if 
the numbers of GFP-Oct4 positive cells are lower in Mad2l2-dedicient aggregates 
(Figure 13). Immunofluorescence analysis revealed that the Erk protein was 
expressed equally, but that the activated, phosphorylated Erk was considerably 
lower in the Oct4-GFP positive cells (Figure 13). Altogether, Mad2l2 protein 





Figure 13: Similarities between PGCLCs and Mad2l2-deficient GFP positive cells. 
Wild-type and Mad2l2 knockout cells express pluripotency related markers. Both somatic 
and germ cells express Erk protein but it is not actived by phosphorylation in germ cells. Bar 
= 25 µm. 
 
  
 Prdm1 (Blimp1) was previously described as a key PGC factor, necessary for 
in induction and differentiation, and detectable in both nascent and migratory PGCs 
(Ohinata et al., 2005). To check the efficiency of the differentiation protocol a ESCs 
line with a Blimp1-membrane-directed Venus reporter (Blimp1-mVenus) was used 
(Ohinata et al., 2008). Eight days after differentiation (six days after BMP4 
treatment), mVenus positive cells were visible in cell aggregates, and thus identified 
as PGCLCs. They expressed higher amount of Mad2l2 in comparison with 





Figure 14: Detection of PGCLCs by expression the Blimp-mVenus transgene and Mad2l2.  
Immunofluorescence exhibited Mad2l2 expression in wild-type D8 aggregates. Note that this 
protein expression is higher in Blimp1-mVenus positive cells. Bar = 50 µm. 
 
 The epigenetic landscape of PGCs is significantly remodeled around E9, in 
particular by a global exchange of the stably repressive histone H3K9me2 by the 
more flexible H3K27me3 (Seki et al., 2007). This process is followed by a global 
demethylation of DNA (Kawasaki et al., 2014). In Mad2l2 knockout embryos PGCs die 
around E9, and the reprogramming is not completed (Pirouz et al., 2013). 
Immunostaining demonstrated that the epigenetic reprogramming failed also in the 
in vitro differentiation of Mad2l2-deficient EpiLCs, which remained strongly positive 




Figure 15: Failure of epigenetic reprogramming during the differentiation from EpiLCs to 
PGCLCs in the absence of Mad2l2.  
a) Immunofluorescence staining of D8 aggregates with antibody against H3K9e2.  
b) Immunofluorescence staining of D8 aggregates with antibody against H3K27me3.  
Bar = 25 µm. 
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 γH2AX is a key modified histone in the DSB repair pathway, and it plays a 
critical role in chromatin relaxation, signal amplification and recruitment of 
downstream factors (Panier and Boulton, 2014). The level of γH2AX is naturally high 
in ESCs, and cannot be explained by the presence of DSBs (Turinetto et al., 2012). 
γH2AX foci accumulated in the Oct4-GFP positive aggregates on D8, and there was 




Figure 16: γH2AX is present in high levels in Oct4-GFP positive aggregates in both wild-type 
and mutant ESCs.  
Immunofluorescence staining of D8 aggregates with antibody against ϒH2AX. Both wild-type 
and Mad2l2-deficient groups show an increase of H2AX phosphorylation in Oct4-GFP 
positive cells. Bar = 100 µm.  
 
 TFAP2C is highly expressed in PGCs, is essential for PGC development, and is 
sufficient for the induction of PGCLCs in vitro in collaboration with PRDM14 
(Magnusdottir et al., 2013; Nakaki et al., 2013). Its expression in Mad2l2-deficient 
cells differentiating in BMP4 medium was investigated by immunocytochemistry. 
After four, six and nine days in BMP medium a large population Oct4-GFP and 
TFAP2C double positive wild-type cells developed, thus identified as PGCLCs. In 
contrast, only a few TFAP2 positive cells were detected on D4 and D9, while none 
were found on D6. The absence of simultaneous GFP expression suggested, that 
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these cell did not represent PGCLCs (Figure 17). In conclusion, the absence of TFAP2 




Figure 17: Failure to induce TFAP2C cells from Mad2l2-deficient ESCs.  
Immunofluorescence staining of D6, D8, and D10 aggregates with antibody against TFAP2C 
(red). This important transcription factor for PGC development was not detected in Mad2l2-




Figure 18: Mad2l2-deficient, GFP positive cells do not express integrin beta 3. 
Immunofluorescence staining of D8 aggregates with antibodies against SSEA1 (white) and 
integrin beta 3 (red). Expression of integrin β3 is specific for PGCs, in contrast to ESCs. 
(Magnification bar is equal with 25 µm) 
 
PGCs and PGCLCs are normally double positive for cell surface markers SSEA1 and 
integrin beta 3 (Hayashi et al., 2011). Indeed, the majority of GFP-positive cells 
derived from wild-type ESCs expressed both of these markers, confirming their 
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PGCLC identity. However, Mad2l2-deficient cells undergoing the same differentiation 
protocol expressed neither integrin beta 3 nor significant levels of SSEA1 (Figure 18). 
These observations confirmed that PGCLCs were not induced Mad2l2-deficient cells. 
 
 Dppa3 is a marker for ICM cells, PGCs, ESCs and PGCLCs (Hayashi et al., 2011; 
Ohinata et al., 2008). The typical, heterogeneous Dppa3 distribution was found in 
condensed cell populations of wild-type D6 aggregates, but much less in Mad2l2 
knockout aggregates (Figure 19a). Expression of Dppa3 mRNA was measured by 
quantitative RT-PCR in the different differentiation stages, namely ESCs, EpiLCs and 
PGCLCs (Figure 19b). In the wild-type group, Dppa3 expression was high in ESCs, low 
in EpiLCs, but back to ESC levels in PGCLCs on D8. In the absence of Mad2l2, Dppa3 
expression was low in ESCs and EpiLCs, and only slightly increased after 




Figure 19: Dppa3 positive cells were not induced 8 days after differentiation of Mad2l2-
deficient aggregates.  
a) Brown dots represent Dppa3 positive cells identified by ABC staining in D8 aggregates. Bar 
= 100 µm.  
b) Expression patterns of dppa3 genes in ESCs, EpiLCs and PGCLCs in both wild-type and 
Mad2l2-deficient groups. Note the general down regulation of dppa3 in both ESCs and 
PGCLCs in the absence of Mad2l2.  
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3.2. DDR in Mad2l2-deficient murine embryonic fibroblasts 
3.2.1. Mad2l2-deficiency leads to activation of a DDR.  
Phosphorylation of the histone variant H2AX by the ATM kinase, and the 
accumulation of γH2AX on single or double strand breaks are immediate early 
responses to DNA damage. Wild-type MEFs did not contain detectable levels of 
γH2AX. Mad2l2-deficient MEFs, on the other hand, regularly contained varying levels 
of γH2AX, even without external damage induction (Figure 20a).  
CHK1 and CHK2 are two kinases which are activated by ATR and ATM 
respectively in response to DNA damage (Cimprich and Cortez, 2008). CHK1 
activation is restricted to the G1 phase of the cell cycle, and CHK2 to S and G2 
(Cimprich and Cortez, 2008). All Mad2l2-deficient MEFs died 24 hours after 
treatment with the DNA cross-linker cisplatin. To study the DDR, exposure time was 
reduced to 8 hours, and pCHK2-positive cells were counted before and after the 
addition of cisplatin. In wild-type MEFs the percentage of pChk2 positive cells rose 
from 0 to ~15% (Figure 20c). In Mad2l2-deficient cells the percentage of positive 
cells was on a high level (~45%) both before and after exposure (Figure 20b, c). A 
higher magnification revealed that pCHK2 accumulated in small dense nuclear foci in 
wild-type cells (Figure 20d). In Mad2l2-deficient MEFs, on the other hand, more 
CHK2 protein was detected around the nucleolus (Figure 20d). In summary, the DDR 
was already activated before exposure to a damaging agent in Mad2l2-deficient 





Figure 20: Activation of a DNA damage response in unexposed and exposed MEFs.  
a) Without exposure to cisplatin MEFs accumulate γH2AX only in the absence of Mad2l2. 
White arrowheads point to cells with a high, confluent amount of γH2AX. Red arrowheads 
point to nuclei with γH2AX foci. Bar = 50 µm. b) pChk2 levels in MEFs before and after an 
eight hour exposure to cisplatin. Bar = 100 µm. c) Quantitation of the experiment depicted in 
panel. d) Distribution of pChk2 in single nuclei of MEFs. Bar = 2 µm. 
 
3.2.2. Cell proliferation is decreased in Mad2l2-deficient MEFs 
Mad2l2-deficient ESCs and EpiLCs cells have a decreased proliferation rate 
(Pirouz et al 2015; 3.1.2.). MEFs were analyzed with an antibody against the 
proliferation-related antigen Ki-67 before and after cisplatin treatment. Around 60 
percent were positive for Ki-67 before exposure to cisplatin, and only 20 percent 
after eight hours of treatment. For Mad2l2-deficient MEFs the percentage dropped 
from 40 to 25 percent (Figure 21). Taken together, the number of proliferative cells 





Figure 21: Proliferation in exposed and unexposed MEFs. 
Marked cells with immunofluorescence staining represent Ki67 positive cells in Mad2l2-
deficient MEFs and wild-type MEFs before and cisplatin treatment. The immunofluorescence 
data were quantified by cell counting. Bar=100 µm. 
 
3.2.3. Histone modifications were misregulated in Mad2l2-deficient MEFs 
after DNA damage. 
A DDR is accompanied by drastic epigenetic changes (Sulli et al., 2012). 
Histone modifications were studied in Mad2l2-deficient MEFs exposed to cisplatin 
for eight hours. In wild-type MEFs, cisplatin exposure induced γH2AX, which then 
correlated to a loss of H3K9me2 expression. In mutant cells γH2AX was already 
present without exposure to cisplatin, and H3K9me2 remained (Figure 22). This 
unique correlation was not observed for H3K9me3 and H3K4me3 (data is not 
shown). The loss of H3K9me2 represents the loss of repressive chromatin and 
formation of relaxed chromatin which is necessary for DDR (Rossetto et al., 2010). 






Figure 22: H3K9me2 histone modification is decreased after DNA damage induction.  
In cisplatin exposed wild-type cells the expression of γH2AX corresponds with the absence of 
H3K9me2 (arrow). In Mad2l2-deficient MEFs γH2AX is expressed both with or without 
exposure to cisplatin, and the expression of H3K9me2 is maintained. 
 
3.3. Characterization of Wild-type and Mad2l2-deficient ESCs  
3.3.1. Mad2l2 is highly expressed in the euchromatin of ESCs 
Mad2l2 RNA as well as Mad2l2 protein levels is extraordinarily high in naive 
ESCs (Figure 23a, c). The level of protein is strongly reduced after differentiation to 
the primed state, and the RNA level is drastically lower in MEFs as compared to ESCs 
(Figure 23b, c). The protein is located in small foci all over the nucleus, excluding 
nucleolus and nuclear lamina (Figure 23e), and associates significantly with the 
chromatin fraction (Figure 23d). Optical sections with the confocal microscope 
revealed that Mad2l2 levels varied from high to barely detectable levels in cells of an 
ESC colony, with a global or a focal nuclear distribution (data not shown). Such a 
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distribution would be expected to result from fluctuating protein levels in a given cell 




Figure 23: ESCs express high levels Mad2l2.  
a) Mad2l2 protein expression in a colony of naive ESCs, and b) in EpiLCs. Bar = 25 µm. c) 
Mad2l2 RNA was detected by qRT-PCR in ESCs and MEFs. d) In ESCs, Mad2l2 protein is 
predominantly localized in the chromatin fraction. e) Nuclear distribution of Mad2l2 protein 
identified by STED microscopy.  
 
 The correlation between Mad2l2 and heterochromatin was investigated by 
double staining for DNA (DAPI) and Mad2l2. DAPI fluorescence was high in the 
nuclear periphery and around the nucleolus, where the level of Mad2l2 protein was 
low or undetectable. Analysis of color intensity by ImageJ software confirmed a 
negative correlation between areas with high DNA contents and Mad2l2 (Figure 24a, 
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b). Mad2l2 did not localize to mitotic chromosomes (Figure 24c). Mad2l2 localization 
was compared with the two heterochromatin markers H3K9me2 and H3K27me3. 
H3K9me2 was present in the nuclear periphery and around the nucleolus, while 
H3K27me3 was detected in the nucleoplasm between nuclear lamina and nucleolus 
(Figure 24d, e). This distribution of heterochromatin and Mad2l2 was mutually 
exclusive, since also in high resolution no overlaps of the staining were detectable. In 
conclusion, Mad2l2 localized to euchromatin, and was specifically excluded from 




Figure 24: Mutually exclusive localization of heterochromatin and Mad2l2. 
a, b) Exclusion of Mad2l2 from areas of high DNA content. Bar = 10 µm. c) Exclusion of 
Mad2l2 from condensed chromosomes d) Mutually exclusive localization of H3K9me2 and 
Mad2l2 as detected by STED microscopy. e) Mutually exclusive localization of H3K27me3 
and Mad2l2 as detected by STED microscopy. Bar = 2 µm. 
 
3.3.2. Comparison histone 3 modifications in wild-type and mutant ESCs 
The level of H3K9me2 was low in the majority of naive, wild-type ESCs, 
however, it increased in Mad2l2 knockout cells (Pirouz et al., 2015). To check this 
increase on a single cell level, cells were counted by flow cytometry. Significant 
differences were revealed between wild-type and mutant cells, when they were 
plotted against each other based on H3K9me2 levels. To quantify cells with low and 
high levels of H3K9me2, the graph was gated to two separate parts based on curve 
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intersection point. This analysis showed that 27% of wild-type cells contained high 
levels of H3K9me2 protein, whereas the percentage increased to 64% for mutant 




Figure 25: H3K9me2 in wild-type and mutant ESCs 
a) White arrows show wild-type and knockout cells with high levels of H3K9me2. b) Three 
replicates of mutant (red) or wild-type (green) populations were analyzed by flow cytometry 
and gave highly similar results. The majority of wild-type cells had low levels of Mad2l2, 
whereas the majority of mutant cells had high levels. Within the high level expressers the 
percentage of mutant cells was larger by a factor of 2, 3 (64%: 27%). Bar = 25 µm. 
 
The natural fluctuation of Mad2l2 levels in a naive ESC population was 
investigated in correlation with the formation of heterochromatin (H3K27me3). High 
resolution microscopy revealed that cells with a high level of Mad2l2 protein always 
had very low levels of H3K27me3 and vice versa (Figure 26a). This negative 
correlation is in agreement with the global increase of heterochromatin markers 





Figure 26: Negative correlation between Mad2l2 and H3K27me3 levels. 
a) The localization of Mad2l2 and H3K27me3 proteins in the nucleoplasm was determined 
by high resolution STED microscopy. Note, that proteins never overlapped, regardless of the 
absolute levels. b) The two heterochromatin markers, H2Aub119 and H3K27me3 are 
increased in Mad2l2-deficient cells. Bar = 2 µm. 
 
3.3.3. No evidence for DNA damage in Mad2l2-deficient ESCs 
Signs for a DDR were observed in Mad2l2-deficient MEFs without a prior 
exposure to genotoxic agents (Figure 20, 3.2.1). Therefore, DDR parameters were 
also studied in ESCs. Here, the pCHK2 level was not raised (Figure 27a). To be sure 
that this was not due to a cell cycle arrest in G1, cells were analyzed by 
flowcytometry after PI staining, revealing a non-significant increase of cells in S 
phase (3%; Figure 27b). There was no arrest of the cell cycle, as confirmed by the 
presence of S and G2 cells in the CHK2-negative population. The transcription of 
genes involved in base excision repair normally increases in response to point 
mutations (Saha et al., 2010). Relevant mRNAs were checked in the transcriptome of 
Mad2l2-deficient ESCs. The levels of Tdg, Xrcc1, Parp1, Apex1, Ercc1, Xpa and 
Gadd45a mRNAs were not increased, and the only significant change was a decrease 
of Gadd45b, a factor responsible for the removal of modified nucleotides (Figure 
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27c). This enzyme contributes to active DNA demethylation by removal of the 5-
hydroxymethylcytosine (Zhang et al., 2011). Chromosome spreads derived from 
synchronized ESCs were checked for abnormalities, but neither joined chromosomes 
nor abnormal formations of centromeres were observed (Figure 27d). In conclusion, 




Figure 27: No evidence for the activation of a DDR. 
a) No activation of the Chk2 protein by phosphorylation occurred in Mad2l2-deficient ESCs. 
b) No significant distortions of the cell cycle were detected in Mad2l2-deficient ESCs. c) The 
only significantly changed DDR mRNA in the transcriptome of Mad2l2-deficient ESCs is 
Gadd45b. Its level would be expected to rise, rather than fall after DNA damage. d) No 
chromosomal aberrations were detected in spreads from synchronized Mad2l2-/--ESCs. Bar = 
25 µm. 
 
3.3.4. Comparison of transcriptomes from wild-type and Mad2l2-deficient 
ESCs 
A first analysis of the raw RNA-sequencing data comparing naive wild-type 
and mutant ESCs was published in 2015 (Pirouz et al., 2015). These data were 
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reanalyzed by new methods to find a correlation between Mad2l2 deficiency and 
developmental instability (see Materials and Methods 2.19). For the alignment of 
sequencing data now the new genomic reference sequence “mm10” was used, while 
previously only mm9 from 2007 could be applied. This increased the aligned 
sequences from approximately 60% to 95%, so that new targets were available for 
comparison. A new statistical tool (Diseq2) increased the sensitivity of the analysis 
(data not shown), which were displayed by volcano plots.  
 A striking finding of the new analysis was the dramatic decrease in the 
expression of Dppa3, identifying it as one of the ten most significantly 
downregulated genes (Figure 28a). Among the top ten upregulated genes was 
Smarcd3 (BAF60c), encoding a subunit of the SWI/SNF chromatin remodeling 
complex, which regulates post-mitotic events in mature cardiomyocytes and 
neurons (Kaji et al., 2006). ESCAPE (http://www.maayanlab.net/ESCAPE/), a new 
database was used for gene ontology analysis. It revealed a significant increase in 
the expression of axonal guidance related genes, which may correspond to the 
significant rise of Smarcd3 (BAF60c) expression. Smarcd3 is a member of BAF 
complex protein, which regulates Dppa3 expression in competition with NurD 
complex (Kaji et al., 2006). Further annotation was performed by ESC applying the 
atlas of pluripotency (ESCAPE) database. This database is able to compare genes list 
with other high throughput studies ESCs (ChIP-sequencing and RNA-sequencing). The 
results showed that a significant number of miss-regulated genes respond similarly 
to a decrease or increase of H3K27me3 and H3K4me3 in the ESCs. This finding is in 
agreement with change in global level of these histone modifications (Figure 28b, 





Figure 28: Comparison of transcriptomes from wild-type and Mad2l2-deficient ESCs 
a) Volcano plot with downregulated genes to the left, and upregulated genes to the right. 
Black dots refer to insignificant changes. Arrows point to dppa3 and smarcd3. Red and green 
dots refer to statistically significant up or downregulated genes, respectively. Green dots 
show log 2 fold change cutoff. b) Molecular function based ontology showed enrichment of 
genes involved in axonal guidance (upper panel). Epigenetic regulation based Ontology 
showed enrichment of genes that are also regulated by H3K27me3 and H3K4me3 (lower 
panel).  
 
Normalized read numbers were calculated with the “Cuff diff” software, and 
the output was arranged relative to the gene position on a chromosome (Figure 29). 
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This analysis revealed three genomic regions on chromosome 13 hosting three major 
histone gene clusters, which exhibited significant increases of transcriptional activity 
in knockout cells (Figure 29). A raw dataset from the public GSE database describing 
transcriptional activities in wild-type and Prdm14-/- ESCs was applied for an 
independent comparison. These data were chosen because of the related phenotype 
between Mad2l2 and Prdm14-deficient ESCs (Grabole et al., 2013). This comparison 
demonstrated that the hyper-activity of the histone gene clusters was unique for the 





Figure 29: Transcriptional activities of histone gene clusters on chromosome 13. 
Raw data of Mad2l2-/- and Prdm14-/- ESC gene expression profile were taken from (Pirouz et 
al., 2015) and (Yamaji et al., 2013), respectively. Data were evaluated by the Cuff Diff 
software and read numbers were arranged against gene position on chromosome. 1, 2 and 3 
point to three gene clusters. Note the principal difference between the two plots, and the 
specific activation of three histone gene clusters in the Mad2l2 mutant cells. 
 
3.3.5. Dppa3 is downregulated in Mad2l2-deficient ESCs 
The downregulation of Dppa3 observed in the RNA-seq analysis was 
confirmed by immunofluorescence and qRT-PCR (Figure 30). To check for a causal 
relation between Mad2l2 and Dppa3 expression, Mad2l2-deficient cells were 
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transfected with a GFP-Mad2l2 expression vector (Figure 31a). qRT-PCR analysis 
demonstrated that the down regulation of Dppa3 mRNA expression was largely 
rescued by Mad2l2 overexpression (Figure 31b). To study the correlation between 
Dppa3 and Mad2l2 heterogeneity, GFP-Mad2l2 was overexpressed in ESCs carrying a 
Dppa3-eCFP reporter. All GFP positive cells co-expressed eCFP, indicating the 
activation of the Dppa3 promoter by Mad2l2 (Figure 31c). ChIP-Seq analysis revealed 
significant increases of H3K9me2 marks on Dppa3 promoter in Mad2l2-deficient cells 
(Figure 32a). Global decrease of both H3K9me2 and H3K27me3 by inhibition of 
Ehmt2 and Ezh2 respectively did not rescue dppa3 expression in ESCs. Altogether, 
Dppa3 expression was not observed in Mad2l2-deficient cells. Both Dppa3 
heterogeneity and absence of expression in Mad2l2-deficient cells was rescued by 
Mad2l2-GFP expression. A global reduction of silencing chromatin marks was not 
enough for the rescue of Dppa3 in the mutant cells.  
 
 
Figure 30: Heterogeneous expression of Dppa3 (white arrows) is not observed in Mad2l2 





Figure 31: Requirement of Mad2l2 for the expression of Dppa3. 
a) Expression of Dppa3 mRNA before and after Mad2l2-deficient ESCs transfection by 
Mad2l2-GFP. Green cells show transfected cells in a ESCs colony. 1 wild-type ESCs, 2 Mad2l2-
deficient ESCs, 3 transfected Mad2l2-deficient ESCs. Note that Mad2l2-GFP overexpression 
in knockout ESCs returned Dppa3 expression to a normal level. b) Mad2l2-GFP 
overexpression in ESCs with Dppa3-eCFP. Green cells show transfected cells and blue color 




Figure 32: Increase of silencing chromatin marker on the promoter of dppa3.  
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a) Significant increase of H3K9me2 on Dppa3 gene promoter. b) Ezh2 inhibitor (GSK) and 
Ehmt2 inhibitor (BIX) reduced H3K27me3 or H3K9me2, respectively, in Mad2l2-deficient 
ESCs. c) Global reduction of H3K27me3 and H3K9me2 did not rescue Dppa3 expression. 
 
3.3.6. Increase of DNA methylation in Mad2l2-deficient ESCs 
A low level of DNA methylation is a key feature of naive pluripotency (Singer 
et al., 2014). The global levels of 5-methylcytosine were measured by dot blot in 
DNAs from LIF2i/serum grown ESCs. DNA methylation was considerably more 
abundant in Mad2l2-/- ESCs, although it did not reach the level of EpiLCs (Figure 33a). 
Cytosine methyl groups are known to be oxidized by Tet1, 2 and 3 enzymes. In LIF/2i 
and LIF/Serum, Tet1 was significantly downregulated in Mad2l2-deficient cells while 
Tet2 and Tet3 downregulation was limited to cells from LIF/Serum medium (Figure 
33b). 
To investigate DNA methylation at a single nucleotide resolution MeDIP-
sequencing was used. BAM correlation analysis confirmed a significant difference 
between wild-type and knockout ESCs, and biological replicates separated clearly 
based on the genetic backgrounds (Figure 34). DNA methylation mostly occurs in 
CpG islands, which can be very small or very large. Analysis of the MeDIP data 
revealed that the differences between DNAs from wild-type and mutant cells were 
mostly insignificant, with the possible exception of single methylation events per 
CpG Island, which were slightly higher in Mad2l2-/- cells. GC% analysis showed that a 
higher percentage of single CG sequences as methylated in Mad2l2-deficient cells 
(data not shown). To study the impact of DNA methylation on gene expression, the 
RNA-seq dataset was compared with the MeDIP-seq data. 221 genes, including 
Zfp42, were methylated in wild-type ESCs, and were unmethylated and upregulated 
in the Mad2l2-deficient ESCs. On the other hand 194 genes, including the 
pluripotency related markers KLF4 and Dppa2, were methylated and significantly 
downregulated in knockout ESCs. Noteworthy, these data also show that the 
overwhelming majority of DNA methylations in Mad2l2-deficient ESCs were not 




Figure 33: Increase of global DNA methylation in the absence of Mad2l2 in the ESCs. 
a) 5mC increased in the absence of Mad2l2. 5-methylcytosine levels in wild-type ESCs, 
mutant ESCs, and wild-type EpiLCs were detected by southern blot. b) Expression of TET 
enzymes in LIF/2i ESCs (1), LIF/Serum ESCs (2) and activin/bFGF grown ESCs (3). Red line: 




Figure 34: BAM correlation analysis by Bed tools.  
Note that wild-type and mutant ESCs from three experimental repeats constitute separate 
groups. 
 
Cytosine methylation is an important mechanism for the regulation of imprinted 
genes. A comparison between the expression of imprinted genes in knockout cells 
and methylated regions revealed that the top five upregulated imprinted genes 
(Peg3, Trp73, Ampd3, Mest, Nnan) were methylated in normal cells, and lost their 
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methyl group in the absence of Mad2l2 (Figure 35). Such a strong correlation was 
not found between downregulated genes and an increase of DNA methylation in the 
knockout ESCs. Taken together, DNA methylation was increased globally in Mad2l2-




Figure 35: Expression of imprinted genes was affected by loss of DNA methylation in 
Mad2l2-deficient ESCs.  
Volcano plot showed expression of imprinted genes in Mad2l2-deficient ESCs in comparison 
with ESCs. Red and green dots refer to statistically significant up- and downregulated genes, 
respectively. Green dots show 2 fold change cutoff. 
 
Sequencing data were annotated by GREAT database, and the result 
exhibited a significant increase of regions occupied by DNA methylation. In wild-type 
ESCs 179 regions, which are not associated with any genes, were methylated and 
this number was increased to 358 in Mad2l2-deficient cells. Increase of methylated 
regions was also observed in genomic region associated with at least on gene region 
from 7163 to 8862. However the distance between methylated areas and TSS did not 





Figure 36: DNA methylation was increased in both gene-associated and non-associated 
genomic area in Mad2l2-deficient cells.  
a) Column chart shows correlation between methyl occupied regions. b) Column chart 
shows average of DNA methylation distance to transcription start site (TSS).  
 
3.4. Mechanistic aspects of Mad2l2 function 
3.4.1. Absence of Mad2l2 from meiotic testicular cells 
 Like ESCs, also testes cells express very high levels of Mad2l2 RNA (Pirouz et 
al., 2013). Cryosections of seminiferous tubes cells were analyzed for the localization 
of Mad2l2 protein in the various cell types generated during spermatogenesis, which 
were identified by morphology and localization (Russell et al. 1990). High levels of 
Mad2l2 protein were detected in the triangular spermatogonial stem cells (cell 
number #1) in the periphery of seminiferous tubules and in spermatids (cell numbers 
#4,#5,#6; Figure 37a). Levels of Mad2l2 were strongly reduced in primary and 
secondary spermatocytes, which undergo the first and the second meiotic division 
(cell numbers #2,#3; Figure 37a). Spermatocytes expressed high levels of γH2Ax foci 
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(Figure 37c, d), which is an indication for ongoing homologous recombination 
(Pacheco et al., 2015; Xu et al., 2015a). This observation is in agreement with 
published findings suggesting an interference of Mad2l2 with homologous 




Figure 37: Mad2l2 protein during spermatogenesis.  
a) A section of a seminiferous tubule shows high levels of Mad2l2 protein in spermatogonial 
stem cells (1) and spermatids (4, 5, 6), but not in spermatocytes (2, 3), and sperm (7). b) 
Histogram of Mad2l2 and DAPI channels. Note the decrease of Mad2l2 expression in primary 
and secondary spermatocytes. c) and d) γH2AX foci in nuclei of spermatocytes, but not of 
spermatogonial stem cells (arrowheads). Bar= 10 µm. 
 
3.4.2. Mad2l2 interacts with DDR factors directly 
To study Mad2l2 interaction partners, the chromatin fraction was isolated 
from both wild-type and Mad2l2 knockout ESCs. Mad2l2 binding proteins were 
immuneprecipitated and analyzed by mass spectrometry. Proteins also found in 
extracts from mutant cells were considered as false positives. Thus, 19 proteins were 
identified by label-free quantification as genuine Mad2l2 interaction partners. These 
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included four factors related to the DDR (MDC1, Histone H1, DNL3 and RuvB), one 
replication factor (MCM5), one chromatin remodeling factor (WD40) and DNA 
methyltransferase (Dnmt1; Figure 38). The strong association between Mad2l2 and 
ATM cascade factors supported the hypothesis that Mad2l2 functions in normal ESCs 
in correlation with this cascade. 
 
 
Figure 38: Mad2l2 interaction partners.  
Green squares represent significantly enriched proteins, orange spheres show insignificant 
interactions. Minimum change cut off is 0.5 (log2). 
 
3.4.3. Inhibition of histone or DNA modifications by small inhibitors in 
Mad2l2-deficient ESCs 
Among the most significant responses to Mad2l2-deficiency in ESCs were the 
upregulation of Zfp42 and the downregulation of Dppa3 expression (3.3.4). In order 
to understand these effects better, rescue attempts were performed by applying 
small molecule inhibitors to Mad2l2-deficient ESCs. Specifically, the histone 
acetylase inhibitors TSA and SAHA, the histone 3 methylation inhibitors GSE and BIX, 
and the DNA methylation inhibitor 5-azacitidine were studied, with the pluripotency 
markers Oct4, Nanog and Sox2 as control read outs. Preliminary experiments 
demonstrated that protein levels of γH2AX and AcH4 were increased as expected 
after 8 h exposures to TSA or SAHA (Figure 39a, b), and histone 3 methylations were 
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reduced as expected after inhibition of the catalyzing enzymes Ehmt2/Ehmt1 or Ezh2 
(Figure 39c).  
 
Expression of pluripotency markers was not affected significantly by any of 
the five inhibitors, with the exception of Sox2 expression, which was reduced by TSA, 
but not in SAHA group (Figure 40). The expression of Dppa3, which is normally 
downregulated in Mad2l2-deficient ESCs was not rescued or affected by any 
inhibitor. However, significant was a decrease of the normally high Zfp42 level 
caused by TSA or SAHA treatment of Mad2l2-/- cells (Figure 40). Together, the 
experiments indicated that the striking downregulation of Dppa3 in the absence of 
Mad2l2 is not a simple consequence of histone acetylation, histone methylation or 
DNA methylation. However, the significant effect of the deacetylation inhibitors on 
the Zfp42 gene may point to a histone deacetylation activity relevant for the Zfp42 




Figure 39: Control experiments in Mad2l2-deficient ESCs.  
a) γH2A was increased after SAHA treatment and maximum level was observed after 8 hours 
treatment. b) AcH4 was increased eight hours after SAHA and TSA treatment of Mad2l2 
knockout ESCs. c) Decrease of H3K9me2 and H3K27me3 confirmed inhibition of Ehmt2 and 






Figure 40: Significant response of Zfp42 expression to inhibition of histone deacetylation.  
Change of Oct4, Nanog, Sox2, Dppa3 and Zfp42 expression in wild-type and Mad2l2-
deficient ESCs exposed to epigenetic inhibitors. TSA = trichostatin A, SAHA, BIX 0129, 
GSK126, 5-azacytidine. Note that TSA and SAHA treated cells expressed significantly lower 
amounts of Zfp42 (pvalue ≤ 0.001).   
 
3.4.4. ATM cascade in the maintenance of pluripotency 
DNA damage normally triggers a complex cascade of factors, which finally allows the 
repair of DNA, and the continuation of the cell division cycle (Goldstein and Kastan, 
2015). In the following this pathway is designated the "ATM cascade", even if ATM 
can often be replaced by ATR or DNA-PK (Ozeri-Galai et al., 2008). ESCs which clearly 
have no indication for DNA damage contain significant levels of ATM cascade 
proteins, in particular γH2AX, RNF168, 53BP1 and Mad2l2 (Figure 41a,b,c,d). γH2AX 
foci were observed in both hetero- and euchromatin (Figure 41e), whereas the other 




Figure 41: High expression levels of ATM cascade factors. 
a-d) High levels of γH2AX, RNF168, 53BP1 and Mad2l2 in ESCs in the absence of DNA 
damage. e) γH2AX is localized in both eu- and heterochromatin. Arrow head shows mitotic 
chromosomes with high levels of γH2AX. f, g, h) RNF168, 53BP1, and Mad2l2 localize to 
euchromatin in ESCs. Bar=25 µm in a,b,c,d. Bar=5 µm in e, f, g, h. i) ATM cascade, factors 
identified in ESCs are in red.  
 
Western blot analysis confirmed the presence of active, i.e. phosphorylated, 53BP1 
in ESCs (Figure 42). Levels of 53BP1 and Nanog were decreased if any of the three 
upstream kinases (ATM, ATR, DNA-PK) was inhibited by specific, small molecule 
inhibitors (Figure 42a), indicating their downstream position in the cascade. On the 
other hand, applying the kinase inhibitors to Mad2l2-deficient ESCs did not change 
the results for γH2AX, 53BP1, or Nanog strongly, confirming the downstream 
position of Mad2l2 in the cascade.  
 
 
Figure 42: Probing the ATM cascade in ESCs with kinase inhibitors 
Analysis of a) wild-type ESCs and b) Mad2l2-deficient ESCs exposed to kinase inhibitors. 
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Since downregulation of Dppa3 was one of the key phenotypes of Mad2l2-
deficient ESCs (3.3.4), its expression was measured by qRT-PCR in ATM-deficient, 
DNA-PK-deficient and H2AX-deficient ESCs. All of these cell lines had decreased 
levels of Dppa3, most significantly the DNA-PK- and the H2AX-deficient cells (Figure 
43a). Mad2l2 expression was reduced only in H2AX-deficient ESCs (Figure 43a), 
suggesting its position downstream in the ATM cascade (Figure 43b). In conclusion, 
the analysis confirms the activity of the ATM cascade in normal ESCs, and its 





Figure 43: Downregulation of Dppa3 in DNA-PK and H2AX deficient ESCs. 
a) Clustered column chart shows change of mRNA levels for Mad2l2 and Dppa3 in wild-type 
and mutant ESCs. b) Deletion of h2AX reduced expression of both mad2l2 and dppa3. 
Mad2l2-deletion reduced dppa3 expression and DNA-PK deletion just reduced dppa3 
expression, without any significant effect on mad2l2 expression.  
 
3.4.5. Colocalization of 53BP1 and H3K27me3 in the ESCs nucleus 
53BP1 promotes open chromatin formation by several mechanisms in response to 
DSB (Zimmermann and de Lange, 2014). High amounts of activated 53BP1 were 
detected in ESCs both in absence and presence of Mad2l2 (Figure 44a). The 
correlation between 53BP1 and the open chromatin status was investigated by 
double immunofluorescence staining for 53BP1 and H3K27me3. Both markers were 
expressed heterogeneously in wild-type ESCs with mutually exclusive expression 
patterns (Figure 44 a). Cells highly positive for 53BP1, for H3K27me3, and for both 
markers were counted separately applying imageJ software. This analysis revealed 
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that the majority of cells were highly positive for just one marker, while only around 
7 percent were double positives (Figure 44c). It suggests a downstream position of 
Mad2l2 in the ATM cascade and confirms a role for Mad2l2 in open chromatin 




Figure 44: The number of double 53BP1 and H3K27me3 positive cells increases in the 
absence of Mad2l2. a) Immunofluorescence staining against 53BP1 (green) and H3K27me3 
(red). Bar=50 µm. 
 b) Three types of cells were identified: only 53BP1 positive green (1), double positive yellow 
(2), only H3K27 positive red (3). c) Quantification of immunofluorescen data in panel a. d) 
ATM cascade in the absence of mad2l2  
 
 
To identify if the negative correlation is Mad2l2 dependent, the same experiment 
was repeated for Mad2l2-deficient ESCs. The number of double positive Mad2l2-
deficient ESCs was considerably increased to approximately 32 percent (Figure 45c). 
Taken together, these data suggest that Mad2l2 functions in the separation of open 
(53BP1) and closed (H3K27me3) chromatin in ESCs (Figure 45d). 
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4. Discussion  
4.1. Failure of germ cell differentiation in the absence of Mad2l2 
Hayashi et al. developed and characterized precisely a protocol for the 
differentiation of ESCs into PGCLCs, which mimics closely the in vivo development of 
PGCs, as evident in transcription profiles, epigenetic reprogramming and cell cycle 
dynamics (Hayashi et al., 2011). This protocol was used to induce the differentiation 
of previously established Mad2l2-deficient ESCs (Pirouz et al., 2015). In the first step, 
highly similar EpiLCs were obtained from mutant and wild-type ESCs (Figure 9). This 
finding is in agreement with the formation of functional epiblast and viable animals 
from Mad2l2 null zygotes (Pirouz et al., 2013). Next, the potential of PGCLC 
induction by BMP4 from Mad2l2-deficient EpiLCs was examined. The initial phase of 
induction occurred similarly, as confirmed by the expression of Oct4, Nanog, Sox2 
and SSEA1. However, the number of GFP-positive cell islands within the aggregates 
of mutant cells gradually decreased, and the typical late germ cell markers TFAP2C 
and Dppa3 were not activated (Hayashi et al., 2011; Seki et al., 2007). Finally, the 
presence of cells was limited to small, incoherent areas close to the center of 
aggregates. Noteworthy, TFAP2C overexpression in combination with Prdm14 
promotes PGCLC differentiation, and TFAP2C knockout mice are infertile due to loss 
of PGCs shortly after their specification at E8.5, similar to Mad2l2-deficient mice 
(Magnusdottir et al., 2013; Nakaki et al., 2013; Pirouz et al., 2013; Weber et al., 
2010). TFAP2C regulates Dppa3 expression directly, and therefore, the absence of 
TFAP2C might explain the downregulation of Dppa3 in Mad2l2-deficient cells [5]. 
Dppa3 regulates the demethylation of retrotransposons in primordial germ cells 
which occupy 39% of the mice genome (Estecio et al., 2010). Therefore, the role of 
Dppa3 as an epigenetic regulator may have a significant impact on the global level of 
DNA demethylation which is a key event during PGC development (Seki et al., 2007). 
Mad2l2-deficient GFP-positive cells failed to switch from a stably repressive 
H3K9me2 dominated chromatin to a more flexible, still repressive chromatin 
dominated by H3K27me3 (Figure 15). These epigenetic abnormalities may finally 
promote apoptosis, as was observed for Mad2l2-deficient cells in Hayashi cultures 
(Figure 12). However, a small population survived even eight days after BMP4 
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treatment. Also in vivo there is evidence for a possible survival of a small number of 
mutant PGCs, as suggested by the rare observation of female gonadal tissues in 
mutant embryos (Pirouz et al., 2013). Altogether, this suggests that Mad2l2-deficient 
cells initiate PGCLC differentiation, but do not complete their development. This 
conclusion would closely fit to the in vivo observations.  
 
4.2. Prolongation of the cell cycle and spontaneous differentiation of 
Mad2l2-deficient ESCs 
Mad2l2 deficient cells show a prolonged cell cycle time that is not in the 
favor of a particular cell cycle phase, and therefore could not be explained by 
previously described interactions of Mad2l2 with APC, Cdc20 or Cdk1 (Pfleger et al., 
2001; Pirouz et al., 2013). There was no distortion of the phases relative to each 
other (Figure 27b). Cell cycle length might correlate with the maintenance of 
pluripotency by at least by two possible mechanisms. First, the fate of ESCs becomes 
restricted into different lineages in preferred phases of the cell cycle (Calder et al., 
2013). Thus, if in absolute terms cells spend a longer time in this phase, the 
likelihood for differentiation is increased. Secondly, ESCs have an ATM activity peak 
during the G2 phase, which enhances Nanog expression (Gonzales et al., 2015). If the 
doubling time is increased, the ATM induced Nanog expression would occur not as 
often as in wild-type ESCs. Less Nanog expression would generate less stable 
pluripotency, which is the observed phenotype of Mad2l2-deficient ESCS grown in 
LIF/Serum (Pirouz et al., 2013). 
4.3. A function of Mad2l2 role in heterochromatin replication  
CHK2 activation normally occurs in the S/G2 phase in response to DNA damage, 
when phosphorylated Chk2 becomes recruited to the damage site next to PCNA. The 
pattern of nuclear pCHK2 accumulation differed significantly between wild-type and 
knockout MEFs. Only in the mutant MEFs pChk2 localized around the nucleolus and 
nuclear lamina, mimicking the accumulation of PCNA and heterochromatic DNA in 
the mid to late S-phase of the cell cycle (Essers et al., 2005). It is conceivable that in 
the absence of Mad2l2 cells is not able to pass through DNA lesions and thus 
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unreplicated DNA remains until the end of S phase, accompanied by pCHK2 
accumulation. However, since DNA damage induced by cisplatin occurs randomly in 
both hetero- and euchromatin, a random distribution including the nucleolus would 
be expected. A second interpretation would suggest a DNA damage-independent 
role of Mad2l2 in the replication of heterochromatin. The time of heterochromatin 
replication is regulated by the Rif1 protein, which is an upstream regulator of 
Mad2l2 (Boersma et al., 2015; Yamazaki et al., 2012). Rif1-recruited Mad2l2 might 
function to open heterochromatin not only during double strand break repair, but 
also during late replication. Thus, Mad2l2 would exert its function as an epigenetic 
regulator, providing access for the replication machinery in heterochromatin. 
 
4.4. Accumulation of damaged DNA in Mad2l2-deficient MEFs, but not 
ESCs 
In MEFs Mad2l2-deficiency promotes an accumulation of spontaneous or 
induced DNA damages, consequently the activation of CHK2, and an arrest of the cell 
cycle, followed by DNA repair (Figure 20, 21). Depending on the type and frequency 
of damage events the repair can be more or less error prone. In ESCs the situation is 
different. These cells have a wide spectrum of developmental possibilities, including 
participation in the germ line. Here, a non-perfect repair of DNA damages could have 
dramatic consequences, and therefore the normal outcome is elimination via 
apoptosis. Neither wild-type nor Mad2l2-deficient ESCs accumulate damaged DNA 
and consequently no recruitment of activated CHK2 was observed. Although the 
level of Mad2l2 is high, no evidence for an active translesion or DSB repair by DNA 
Pol zeta subunits Rev3 and Rev7 (=Mad2l2) was observed, in particular no cell cycle 
arrest and no increase of γH2AX foci (Figure 28b). 
4.5. No naive pluripotency in the absence of Mad2l2 
Metastable ESCs fluctuate between the naive and the primed state, as 
evident by variable levels of methylated DNA, pluripotency related factors and early 
lineage commitment markers (Tajbakhsh et al., 2015). Independent from culture 
conditions (LIF/2i or LIF/serum) Mad2l2-deficient ESCs are never bona fide naive 
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ESCs. They do not express the naive ESC marker Dppa3, which is essential for 
generating high quality induced pluripotent stem cells, and also relevant for the 
quality of ESCs. This phenotype cannot be rescued by an inhibition of histone 
deacetylase, and is independent of DNA methylation (Figure 33a) and histone 
modifications (H3K9me2 and H3K27me3). The fluctuation of Dppa3 expression 
corresponds to the observed heterogeneity of Mad2l2 expression. Loss of Dppa3 
expression could be rescued by Mad2l2 (3.3.5). zfp42 (Rex1) is another misregulated 
gene in Mad2l2-deficient ESCs. This protein is important for triggering visceral 
endoderm differentiation of ESCs (Masui et al., 2008). In Mad2l2-deficient ESCs the 
level of Zfp42 is significantly elevated as compared to wild-type cells, in LIF/serum 
medium even higher than in LIF/2i medium. This finding corresponds to the 
spontaneous differentiation into visceral endoderm observed for Mad2l2-deficient 
ESCs (Pirouz et al., 2013). The Zfp42 expression level could be reduced to wild-type 
levels by inhibition of histone deacetylase, suggesting that the increase of Zfp42 is an 
indirect effect of the Mad2l2 knockout (Figure 40). 
The epigenetics of Mad2l2-deficient ESCs are not typical for pluripotency. Global 
reduction of DNA methylation is one of the major characteristics of a naive ESC 
epigenome (Figure 33). Mad2l2-deficient ESCs, however, do not reduce DNA 
methylation to the level of wild-type cells, an effect possibly related to the loss of 
Dppa3 expression. Dppa3 protein is an H3K9me2 binder and has dual effects on DNA 
methylation (Nakamura et al., 2012). It promotes general demethylation by 
competing with Uhrf1, and protects maternally imprinted genes by interaction with 
H3K9me2 and inhibition of Tet3 (Bian and Yu, 2014). In addition there are several 
reports about a direct interaction of Mad2l2 with Dnmt1 (Hein et al., 2015; 
Vermeulen et al., 2010), which was confirmed by co-precipitation and mass 
spectrometry (Figure 39).  
 
4.6. Promotion of open chromatin versus suppression of 
heterochromatin by Mad2l2 
Both LIF/2i and LIF/Serum ESCs have a generally open chromatin (Meshorer 
and Misteli, 2006). Mad2l2 is typically localized in nuclei in association with eu-, but 
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not heterochromatin. Within an ESC colony levels of the Mad2l2 protein fluctuate, 
similar to the described stochastic expression of some early lineage specification 
markers (Gata4, Gata6 and Sox17) or some pluripotency related factors (Nanog, 
Dppa3; 3.3.1). Since the highly negatively charged Mad2l2 protein does not contain a 
DNA binding domain it is not associated with specific genomic loci. However, all 
HORMA domain proteins including apparently Mad2l2 are able to sense chromatin 
states (Fattah et al., 2014; Rosenberg and Corbett, 2015). The euchromatic 
localization of Mad2l2, the increase of heterochromatin upon deletion and its 
interaction with heterochromatin factors like POGZ, CBX3, Dnmt1, and Ehmt1 
suggests that Mad2l2 actively promotes euchromatin and suppresses 
heterochromatin.  
 Mad2l2 could be recruited to euchromatin via PCNA, which provides a 
platform for the recruitment of factors involved in replication, epigenetic regulation 
and DNA repair. Such factors include DNA pol zeta (Rev3/Rev7), but noteworthy also 
Rev7 (= yeast homolog of Mad2l2) alone (Fattah et al., 2014). A major constituent of 
heterochromatin is the methylated histone H3K9me2. Levels are globally low in both 
E3.5 ICM and in LIF/2i-cultured ESCs (Zylicz et al., 2015). With implantation 
heterochromatin markers increase significantly in the epiblast, and a similar increase 
occurs during the transition from naive to primed ESCs (Zylicz et al., 2015). Crucial 
methyltransferases for the formation of H3K9me2 are Ehmt2/Ehmt1, which would 
be a target for the suppression of heterochromatin. It was previously described that 
Ehmt2/Ehmt1 co-precipitate with Mad2l2, suggesting an anti-heterochromatin 
activity of Mad2l2 via direct, inhibitory interaction (Pirouz et al., 2013). 
 
4.7. Mad2l2: an epigenetic regulator in pluripotency and DNA damage 
The activation of ATM, ATR and/or DNA-PK kinases is typically observed 
immediately after the induction of DNA damage (Ciccia and Elledge, 2010). A major 
target of these kinases is the histone variant H2AX, which becomes phosphorylated 
into γH2AX. Both wild-type and Mad2l2-deficient ESCs have a high number of 
nuclear γH2AX foci, which is necessary for the maintenance of pluripotency, as 
previously shown (Ahuja et al., 2016; Turinetto et al., 2012), and also exemplified in 
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this study by the downregulated Nanog expression after kinase inhibition (Figure 42). 
ATM/γH2AX triggers the recruitment of many important factors for DSB repair, such 
as the ATM, H2AX, MDC, RNF8, RNF168, 53BP1, and Rif1 (Zimmermann and de 
Lange, 2014). These proteins are also expressed at a high, constitutive level in the 
euchromatin ESCs, noteworthy in the absence of any evidence for DNA damage 
(Turinetto et al., 2012).  
Thus, an ATM cascade is constitutively activated in ESCs, which among others 
induces various histone modifications, in particular the phosphorylation by ATR, 
ATM, or DNA-PK, or the ubiquitylation by E3 ligases RNF8 or RNF168. An important 
consequence of the cascade is the relaxation of chromatin, which occurs locally at 
damage sites, and globally in ESCs. The recruitment of 53BP1 promotes the 
formation of open chromatin. In the absence of 53BP1, accumulation of 
heterochromatin writers (Dnmt1, Suv39h1) and readers (CBX1, 3) next to the γH2AX 
foci was reported (Ayrapetov et al., 2014; Broering et al., 2014; Ha et al., 2011). 
However, 53BP1 alone is not enough for the maintenance of an open chromatin 
status of ESCs, and Mad2l2 was described to function as a downstream effector 
(Boersma et al., 2015; Xu et al., 2015a). Suggested molecular mechanisms include 
the inhibition of histone methyltransferase Ehmt2, the blocking the cell cycle 
regulator Cdk1, which would otherwise block 53BP1 recruitment, or the binding of 
Dnmt1 (Figure 45; (Pirouz et al., 2013).  
The expressions of both Mad2l2 and of its target gene Dppa3 are affected by 
the absence of H2AX in ESCs, suggesting a function of γH2AX upstream of Mad2l2 
and Dppa3 (Figure 43). However, DNA-PK deletion in ESCs reduced Dppa3 
expression, without a significant effect on Mad2l2 expression. This finding is in 
agreement with the known hierarchy in NHEJ repair, and promotes the idea that 
Mad2l2 regulates Dppa3 expression via DNA-PK (Figure 43b). These molecular 
connections indicate, that the linear representation of the ATM cascade does not 
cover the whole complexity of the events in DNA damage and ESC chromatin 
regulation. Newly recruited factors regulate the processes by negative and positive 
feedback loops, so that the process cannot be represented adequately as a one 
directional pathway. The model in Figure 45 represents a more static view on the 
described molecular situation both for open and for compact chromatin.  
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In conclusion, it occurs that in ESCs the major importance of DNA repair 
factors including Mad2l2, here discussed as the ATM cascade, lies in their epigenetic 
functions, namely to keep the ESC chromatin in a constitutively and globally open 
configuration. The described evidence supports a function of Mad2l2 as an 
epigenetic regulator in the context of other regulatory proteins, many of them 
known from the response to DNA damage. The function of Mad2l2 in DNA repair and 
in the maintenance of ESCs and PGCs may indeed represent different aspects of the 




Figure 45: Mad2l2 as an epigenetic regulator promoting open chromatin in ESCs and after 
DNA damage.  
For discussion see text in 4.6. and 4.7. The figure is extended and modified from a previously 
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